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SUMMARY 
 
Introduction 
The Timed Up and Go is an outcome measure which has been shown to be reliable 
and valid to assess change in patients post hip fracture. Advances in technology have 
included the use of inertial sensors for the quantitative analysis of the Timed Up and 
Go (QTUG) and enhance the scope for harnessing information from the test. 
However no studies have investigated their use in hip fracture patients. 
 
Aims and Objectives  
The aim of this study was to investigate the use of the QTUG in the assessment of 
hip fracture patients in a sub-acute geriatric rehabilitation setting. This included 
investigating which components of the QTUG were sensitive to change pre and post 
rehab and investigating the use of the QTUG as a measure of falls risk and frailty 
level.  
 
Methods  
A prospective cohort study design was employed using a sample of convenience. 
Sixteen participants post hip fracture admitted to an inpatient post-acute 
rehabilitation unit were assessed on admission and at discharge using the QTUG. 
Individual components of QTUG (e.g. sit to stand, walk, turn time) were compared 
between admission and discharge. Falls risk and frailty level were also assessed 
using QTUG and these were compared to secondary measures of Tinetti Gait and 
Balance Assessment and Clinical Frailty Scale (CFS). 
 
Results 
There was a significant improvement in the main outcome measure of overall QTUG 
time between admission and discharge of 9.3 (95% CI 5.6 to 12.9) seconds with a p 
value <0.001. Each individual time component of the QTUG (sit to stand, walking, 
turning, stand to sit) also showed statistically significant improvements.  
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There was a significant improvement in both falls risk and frailty level estimates 
measured using the QTUG and using clinical outcome measures of Tinetti and CFS. 
There was a strong negative correlation between the QTUG falls risk estimate and 
Tinetti scores on admission (r=-0.673, p=0.004) and discharge (r=-0.764, p=0.001). 
There was no relationship between QTUG frailty level and CFS on admission 
(r=0.222, p=0.409), however there was a strong correlation on discharge (r=0.699, 
p=0.003). 
 
Conclusions 
The QTUG was a sensitive measure to assess for changes in functional mobility 
between admission and discharge for hip fracture patients. The QTUG may also 
provide a useful adjunct to falls risk and frailty level assessment on discharge.  
 
Implication of Findings  
Further prospective longitudinal research should be conducted to investigate the 
long-term outcome of hip fracture patients, using the QTUG to identify ongoing gait 
difficulties and to assess the predictive ability of the falls risk and frailty level 
estimates.   
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INTRODUCTION 
Hip fractures and their management are a major challenge to our health care system 
and to our society. Hip fractures are considered the most significant fragility fracture 
in the elderly and are associated with high levels of morbidity and mortality. The 
costs of this epidemic on society are great, in human as well as in economic terms, 
and much of our care processes are suboptimal (British Orthopaedic Association, 
2007). 
Every year in Ireland over 3000 people are hospitalised due to hip fracture, resulting 
in high healthcare costs of 35 million euro (Irish Hip Fracture Database, 2014). A 
growing older population will mean that these numbers will continue to increase and 
place more demands on our healthcare system. By 2046, approximately 21% of the 
Irish population will be aged 65 years or older, and approximately 7% will be aged 
80 years or older, where the corresponding figures for 2011 were 11.6% and 2.8% 
respectively (TILDA, 2014). 
Hip fractures are regarded as the most severe type of fragility fracture with a 20-30% 
mortality rate within one year of fracture (McGowan et al, 2013). NICE guidelines 
also show that approximately 20% of people who were previously living in the 
community are discharged directly to nursing homes post hip fractures. There is a 
strong recommendation for early identification of patient’s individual goals for 
multidisciplinary rehabilitation to recover mobility and independence, and to 
facilitate return to pre-fracture residence and long-term wellbeing (NICE Guidelines, 
2011).    
Hip fractures are primarily caused by accidental falls and are related to pre-existing 
mobility and balance problems and multiple health problems (Dargent-Molina et al, 
1996). Depending on the population being studied it is estimated that 25-75% of 
those who are independent walking prior to fracture can neither walk independently 
nor reach their previous level of mobility one year post hip fracture (Magaziner et al, 
2000). To regain this pre-fracture functional level, regaining independent mobility 
through rehabilitation is an essential first step and is associated with a better outcome 
post hip fracture (Kristensen et al, 2007).  
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A poor mobility score is also a significant risk factor of suffering further falls and a 
second hip fracture, with a further reduction in function. Pearse et al (2003) showed 
that up to 12% of patients with a hip fracture went on to have a second hip fracture. 
Assessment of patients’ mobility levels, falls risk and frailty levels are of the utmost 
importance in rehabilitation units to prevent further falls as inpatients and on 
discharge (Kristensen et al, 2007).  
Measuring rehabilitation outcome in hip fracture patients is a crucial element in 
evaluating effectiveness of healthcare interventions (Hershkovitz et al, 2015). The 
Timed Up and Go (TUG) is one outcome measure which has been shown to be 
reliable and valid to assess change in orthopaedic patients (Yeung et al, 2008).  The 
TUG is a measure of functional mobility which assesses the basic activities of daily 
living of standing up from a chair, walking and turning (Podsiadlo and Richardson, 
1991). 
The TUG is widely used to provide valuable information on falls risk assessment, 
functional decline or frailty and to measure for changes in various populations 
(Sprint et al, 2015). The TUG is measured by the overall time taken to complete the 
test and it has been indicated that a TUG score of greater than 13.5 seconds indicates 
a high risk of falls (Shumway-Cook et al, 2000). However, by only measuring the 
overall time taken to complete the test, it does not give an indication of which 
component of the test that the subject is having difficulty with (Wall et al, 2000).  
Recent advances in technology have included the use of body worn inertial sensors 
for the TUG, which enhance the scope for harnessing quantitative information from 
the test, beyond just the time taken to complete the test (McGrath et al, 2011). With 
the addition of inertial sensors to the TUG, further parameters relating to component 
timing, gait and balance are extracted out of a test that previously yielded only the 
total duration (Sprint et al, 2015). Recent studies have included the use of inertial 
sensors and technology to investigate falls risk and frailty level in community 
dwelling elderly (Greene et al, 2014a; Greene et al, 2014b; Greene et al, 2016) and to 
assess mobility in patients with stroke, Multiple Sclerosis and Parkinson’s Disease 
(Vernon et al, 2015; Greene et al, 2015; Weiss et al, 2010). 
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The aim of this study was to investigate the use of inertial sensors in the assessment 
of hip fracture patients in a sub-acute geriatric rehabilitation setting. This included 
investigating which components of the ‘Timed Up and Go’ were sensitive to change 
pre and post rehabilitation in patients with hip fractures and comparison of the Falls 
Risk and Frailty Level Estimates generated from the inertial sensor analysis to 
standardised falls risk and frailty measures.  
Secondary aims of this study were to investigate which baseline patient 
characteristics were associated with improved functional mobility on discharge from 
sub-acute rehabilitation post hip fracture and comparison of hip fracture patients’ 
sensor-derived gait parameters on discharge from hospital to normative data for 
community dwelling elderly population. 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1  Hip Fractures 
Hip fracture is an increasing public health issue due to our ageing population. Every 
year over 3000 people are hospitalised with hip fracture resulting in high healthcare 
costs of 35 million euro (Irish Hip Fracture Database 2014). Hip fractures are 
associated with high rates of morbidity and mortality. Approximately 10% of people 
with hip fracture die within one month and one third within one year (NICE 
guidelines, 2011). Additionally, 10-20% of survivors have been shown to require a 
change to a more dependent residential setting (Rosell et al, 2003). 
Hip fractures have been demonstrated to be a concern for healthcare worldwide. An 
estimated 1.26 million fractures occurred in 1990 and this is predicted to rise to 7.3 
to 21.3 million by the year 2050 (Gullberg, 1997). In industrialised countries, the 
mean age of people sustaining hip fractures is 80 years old and 80% of this 
population are female (Handoll et al, 2009). Lifetime prevalence of sustaining a hip 
fracture is estimated at one in six for females and approximately double this for 
males (Cummings et al, 2002).  
Hip fracture as a result of falls has been related to mobility and balance impairments, 
osteoporosis, visual and other health problems (Dargent-Molina et al, 1996 and 
Kristensen et al, 2007). Furthermore, 12% of patients with hip fracture go on to 
suffer a second hip fracture with a significant decline in their mobility and 
independence (Pearse et al, 2003). Many patients do not regain premorbid level of 
mobility and function (Rosell et al, 2003 and Stenvall et al, 2005).  
A review conducted by Bertram et al (2011) into the long-term disability associated 
with hip fractures showed that 42% of survivors do not return to their pre-fracture 
level of mobility, 35% are incapable of walking independently, 20% are unable to 
shop independently and 20% enter a long term facility during the first year after 
fracture. The results of this review show that original calculations of hip fractures 
and the Global Burden of Disease (2013) assumptions may be underestimated and 
that the long term consequences and costs of these injuries may be more significant 
than estimated. 
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Most hip fractures require surgical intervention after which there are a number of 
interventions required to assist recovery (SIGN, 2009). Rehabilitation is defined as 
services provided by a multidisciplinary team with the goal of reducing disability 
and restoring task-oriented behaviours (Handoll et al, 2009). Kristensen et al (2009a) 
describes regaining basic functional mobility as the first key step in returning to 
premorbid level of functioning and rehabilitation units play a key part in patients’ 
recovery post hip fracture. 
 
1.2  Outcome Measurement: Timed Up and Go 
Outcome measures are used in rehabilitation to establish a baseline description, 
screen for risk factors or undetected problems, assist in diagnosis, set therapeutic 
goals and monitor patients’ clinical progress (Mendelsohn et al, 2003). The ‘Timed 
Up and Go’ (TUG) is a test of functional mobility that measures the time in seconds 
that it takes a person to rise from a chair, walk 3 metres, turn and sit down in the 
chair again (Podsiadlo and Richardson, 1991).  The TUG is a test that can be used to 
quantify basic functional mobility in patients post hip fracture as well as for 
evaluating clinical change over time (Ingemarsson et al, 2003). 
Many studies have investigated the validity of the TUG as an outcome measure in 
orthopaedic and geriatric rehabilitation. Brooks et al (2006) reported that the TUG 
showed large responsiveness to a rehabilitation program that occurred between 
admission and discharge in a geriatric rehabilitation setting and has moderate to 
strong correlations with functional ability. Yeung et al (2008) demonstrated that the 
TUG is a reliable and valid test to assess group change in inpatients on an 
orthopaedic ward. The TUG has also been shown to be a useful assessment tool as it 
does not suffer from ceiling or floor effects (Herman et al, 2011).  
The TUG is also a screening tool which is used frequently in community and 
inpatient settings to identify those who are at high risk of falling. Shumway-Cook et 
al (2000) examined the sensitivity and the specificity of the TUG for identifying 
elderly individuals who are prone to falling and determined a score of >13.5 seconds 
as a cut-off point for those at higher risk of falling. However, a systematic review 
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and meta-analysis conducted by Barry et al (2014) concluded that the predictive 
ability of the TUG time alone may be limited as falls are multifactorial in nature. 
 
1.3  Advances in Technology: Quantifying the Timed Up and Go 
While the TUG has been shown to be a useful outcome measure it has limitations in 
that performance is only measured by the overall time taken to perform the task. 
Wall et al (2000) hypothesised that if the individual components of the TUG could 
be measured that this would provide more clinically meaningful information 
regarding the aspect of mobility that patients are having difficulty with. Recent 
literature has focussed on the use of technology to quantify the quality of movement 
which cannot be measured by performing standard TUG.  
Technology has become more advanced, accessible and inexpensive than ever 
before. Many different forms of technology have been utilised in recent research to 
quantify the TUG, including video-based technology, wearable inertial sensors, 
smartphone-based technology and ambient sensors. Sprint et al (2015) performed a 
review of the studies (n=30) using technology to quantify the TUG. In this review, 
video-based technology was used in 7 of the studies. Advantages of video-based 
analysis included that the test is re-playable for scoring at a later time, and that 
hardware is not required to be worn or attached to the body. There are disadvantages 
however, as the cameras need to be well-positioned and have a fixed setting, and 
lighting and surface of flooring can interfere with recording.  
Smartphone-based technology is now also being utilised in healthcare tests and was 
used in 4 studies in this review. Advantages of using smartphone technology include 
that they can be mounted on the body or carried in pockets or bags and are easy to 
use. Disadvantages are that they are bulkier than inertial sensors and need to be well-
positioned and oriented, and that they require internet connection to upload data. 
Wearable inertial sensors were the most commonly used technology in quantifying 
the TUG and were used in 18 studies included in this review. Inertial sensors consist 
of accelerometers and gyroscopes and directly measure angular velocity and linear 
acceleration of body segments, from which temporal and spatial gait parameters can 
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be measured (Howcroft et al, 2013).  There were some disadvantages identified with 
the use of sensors, as they need to be routinely charged, and need to be well-
positioned and oriented or they can suffer from noise or drift.  However there were 
many advantages of inertial sensors such as their small, inconspicuous size, their 
ability to be attached easily to the body, they are inexpensive and they are wireless 
and portable meaning testing space is not constrained.  
 
1.4  Development of Quantitative Timed Up and Go (QTUG) 
The Quantitative Timed Up and Go (QTUG) was developed over seven years of 
research by Kinesis Health Technologies who are linked with University College 
Dublin and the Technology Research for Independent Living Centre, a large ageing 
research project.  They have used Shimmer technology to develop inertial sensors 
which can be used to quantify the Timed Up and Go test and provide temporal and 
spatial gait parameter measurement that cannot be captured using standard TUG 
measurement of time alone (Figure 1.1). The QTUG was developed for use as an 
objective assessment of gait and mobility, measurement of response to rehabilitation 
and treatment, as well as screening for fall risk, mobility impairment and frailty. 
 
Figure 1.1 QTUG Inertial Sensors and Set-up 
Experimental setup for instrumenting the timed up and go with inertial sensors.  
The red cross on the floor denotes the turnaround point. Shimmer inertial sensor 
(5.4 cm × 1.9 cm × 3.2 cm) with coordinate axes (right). Greene (2012) 
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Figure 1.2 Sample Data Report from QTUG 
Fall Risk and Frailty Estimates, Comparison to Population Average and Temporal 
and Spatial Gait Parameters 
 
1.5  Clinimetric Properties of QTUG 
The reliability of the QTUG has been assessed in a number of populations. McGrath 
et al (2011) investigated the reliability of QTUG variables for the use of falls risk 
assessment. This study investigated both the intra-session reliability, where six 
repetitions of TUG were performed with one-minute rest between, and inter-session 
reliability, where these measures were repeated four weeks later. Healthy community 
dwelling participants (n=33) aged 55-65 years old were recruited to partake in this 
study. A total of 44 QTUG parameters were measured from sensors attached to the 
shanks and lower backs of the participants. Results for intra-session reliability 
showed excellent reliability for 25 of the parameters (ICC>0.75) and fair to good for 
12 parameters (ICC 0.4-0.75). Turning parameters demonstrated poor reliability 
(ICC<0.4). Inter-session reliability analysis demonstrated similar results. It was 
concluded that the QTUG was overall a reliable measure and was suitable for use in 
longitudinal fall risk assessment and recommended further development to improve 
reliability of turn parameters. 
9 
 
Another study into the reliability of the QTUG was conducted by Greene et al (2015) 
comparing the reliability of shank mounted inertial sensors in people with MS 
compared to healthy controls. The mobility of 38 people with MS and 33 healthy 
controls were assessed using QTUG. In comparison to the previous study by 
McGrath et al (2011) only the intra-session reliability was investigated, and 
reliability was assessed across three consecutive tests instead of six. Similar to the 
previous study, intra-session reliability analysis showed that 36 out of 53 gait 
parameters had excellent reliability with a further nine parameters showing moderate 
strength reliability. The reliability of these parameters compared favourably in both 
groups of people with MS and healthy controls. 
Further investigation into reliability of QTUG was performed by Smith et al (2016) 
in healthy subjects performing the TUG under single and dual task conditions. A 
small sample of subjects (n=12) were requested to perform the standard TUG (single 
task) and motor and cognitive (dual task) conditions over five consecutive days. 
Parameters again were derived from sensors attached to the shanks of participants 
and 21 parameters were assessed for reliability. Results showed strong/moderate 
reliability (ICC>0.70=strong, ICC 0.40-0.70=moderate) for thirteen of the 
parameters under all three conditions. Results showed poor reliability (ICC<0.40) for 
turn and variability parameters, similar to the findings of the previous two studies. 
Poorer reliability was also shown when the TUG was performed under dual task 
conditions and caution was advised in the interpretation of results obtained from dual 
task testing. The authors concluded that certain sensor derived parameters provide 
additional information into the longitudinal assessment of patients. The results of the 
reliability testing and ICC values for the QTUG parameters for the three trials are 
displayed in Appendix 1.  
 
1.6  Falls Risk Assessment 
Falls risk assessment is necessary post-hip fracture and is recommended by NICE 
guidelines (2011) and the British Orthopaedic Association (2007). Many patients 
post-hip fracture go on to suffer further falls, and 12% have been estimated to go on 
to suffer a second hip fracture (Pearse et al, 2003). Assessment of patients’ mobility 
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levels, falls risk and frailty levels are of the utmost importance in rehabilitation units 
to prevent further falls as inpatients and on discharge (Kristensen et al, 2007). 
Sensor-based assessments and clinical outcome measures are two different methods 
which may be used to assess falls risk. 
 
1.6.1  Falls Risk Estimate: QTUG 
Inertial sensors have the potential to provide a quantitative, objective, and reliable 
indication of falls risk in the geriatric population (Howcroft et al, 2013). The concept 
of this falls risk measurement involves the analysis of signals collected during 
movement via body-worn inertial sensors and the use of algorithms to predict falls 
risk (Shany et al, 2012). 
Greene et al (2010) reported an objective method for assessing falls risk using the 
QTUG. The gait and balance of 349 community-dwelling elderly adults was assessed 
using the inertial sensors while each patient performed the TUG. Patients were also 
assessed using the Berg Balance Scale (BBS).  Of the 44 reported parameters derived 
from body-worn kinematic sensors, 29 provided significant discrimination between 
patients with a history of falls and those without. Logistic regression models cross-
validated with retrospective falls prediction yielded a mean sensitivity of 77.3% and 
a mean specificity of 75.9%. This compared favourably when compared to TUG 
time alone and BBS which yielded mean sensitivities of 58.0% and 57.8%, and mean 
specificities of 64.8% and 64.2% respectively. A limitation of this study however, 
was that it used retrospective falls history which can be subject to bias. 
A prospective study evaluating falls risk in community-dwelling older adults using 
QTUG was completed by Greene et al (2012). Data were acquired from sensors 
worn on the left and right shanks of 226 participants while performing TUG. 
Participants were then contacted 2 years following their initial assessment to 
determine if they had fallen. Results obtained through cross-validation regression 
model yielded a mean classification accuracy of 79.69% (95% CI: 77.09–82.34) in 
prospectively identifying participants that fell during the follow-up period. These 
results were significantly more accurate at predicting falls than those obtained from 
TUG time alone and BBS. 
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A review by Barry et al (2014) identified that falls are multi-factorial in nature, and 
TUG in isolation may have limited ability to predict falls. Greene et al (2016) 
investigated a method of combining inertial sensor data with clinical risk factors (e.g. 
previous falls, polypharmacy, vision impairment, and orthostatic hypotension).  
Results of this study (n=292 community dwelling older adults) showed that a 
combined clinical and sensor-based approach yields a classification accuracy of 
76.0%, compared to either 73.6% for sensor-based assessment alone, or 68.8% for 
clinical risk factors alone. 
 
1.6.2  Fall Risk Assessment: Clinical Outcome Measures 
Clinical balance assessment can help assess falls risk and determine the underlying 
reasons for decreased balance (Mancini and Horak, 2010). The Tinetti Gait and 
Balance Assessment (Tinetti, 1986) is a 16-point scale divided into two parts to 
assess older adults gait and balance abilities and is one of the most widely used tools 
used amongst older people (Yelnik and Bonan, 2008). The Tinetti has been shown to 
have excellent inter (ICC=0.84) and intra-rater reliability (ICC=0.96) in an elderly 
population (Sterke et al, 2010; Thomas et al, 2005). The Tinetti Gait and Balance 
Assessment is suitable for use for ortho-geriatric patients post hip fracture surgery 
who may be under post-operative hip restrictions. 
 
1.7  Frailty Level Assessment 
Frailty is a syndrome which is characterised by a diminished physiological response 
to stressors such as an acute illness or psychological distress (Fried et al., 2001). 
Frailty and its accompanying mechanisms such as inactivity, decreased strength and 
weight loss are linked with osteoporosis, increased falls and resultant hip fractures 
(Rolland et al, 2008). The assessment of frailty is an important baseline measure and 
outcome tool to use in the rehabilitation of hip fracture patients as it can be 
predictive of outcome or further debilitation post fracture (Krishnan et al, 2013). The 
following is an evaluation of two different methods of measuring frailty level; 
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Sensor-based QTUG and clinical outcome measure: The Clinical Frailty Scale 
(CFS).  
 
1.7.1  Frailty Level Estimate: QTUG 
The TUG has been identified as a simple measure of mobility that may be a useful 
proxy for frailty. As low gait speed is one of the criteria for Fried’s phenotype of 
frailty it was hypothesised that TUG may also be indicative of frailty. Savva et al 
(2013) described the distribution of frailty and TUG performance among 1,814 
community dwelling elderly participants as part of the Irish Longitudinal Study of 
Ageing. They found that while the TUG was able to identify frail members of the 
population well (AUC=0.87) but was less able to discriminate the non-frail from pre-
frail populations.   
Greene et al (2014) investigated the use of QTUG as a method of identifying frailty 
in community dwelling elderly population (n=399). Results demonstrated that using 
inertial sensor data, participants were classified as frail or non-frail with mean accuracy of 
75.20% (stratified by gender). Using TUG time alone, frailty status was classified correctly 
with mean classification accuracy of 71.82%. The results of this study show that a simple 
protocol using the TUG and inertial sensors can be a fast and effective means of automatic 
assessment of frailty. 
 
1.7.2  Frailty Level Assessment: Clinical Outcome Measures  
The Clinical Frailty Scale (CFS) is an effective measure of frailty and had been 
validated in a geriatric rehabilitation setting (Rockwood et al, 2005). The CFS was 
developed as part of the Canadian Study of Health and Ageing. A Frailty Index was 
determined for 2,305 older people and each was assigned to one of seven categories 
on the CFS ranging from ‘very fit’ to ‘severely frail’. The CFS is scored based on 
clinical judgement, is easy to use and can be readily administered in a clinical 
setting. Rockwood et al (2005) also showed that the CFS was highly correlated with 
the Frailty Index (r=0.80). 
13 
 
1.8  Gait Analysis 
1.8.1  QTUG Component Analysis 
Further clinically meaningful information may be gathered by analysing the various 
components of the QTUG rather than analysing the TUG as a whole. There are a 
number of separate tasks involved in the TUG: sit to stand, walking, turning and 
stand to sit. Wall et al (2000) identified that by measuring TUG just by overall time 
to complete the task that this may mask difficulties that a patient is having with one 
particular component.  This can guide the clinician in guiding treatment and devising 
prevention strategies.  
In patients with Parkinson’s Disease the use of inertial sensors while performing 
TUG has been found to have good utility in quantifying which component of the task 
the patient is having difficulty with (e.g. sit to stand, initiation of gait, turning). It has 
also been shown to augment the evaluation of disease progression and response to 
therapeutic interventions (Salarian et al, 2010 and Weiss et al, 2010). 
 
1.8.2  Gait Parameters 
Many studies have been conducted to investigate the changes in gait that occur in the 
ageing population and how these can be linked to increased number of falls (Menz, 
2003). A consistent finding is that older people tend to develop a slower gait speed, 
which is a result of both a shorter step length and increased time spent in double 
limb stance (Oberg et al, 1993 and Bohannon et al, 1997). In addition to gait speed, 
gait variability parameters may also be indicators of frailty status.  Increased step 
width variability has been shown to be increased in pre-frail compared to non-frail 
populations. Increased step width variability has also been linked to impaired 
balance control and increased likelihood of falls (Bohannon et al, 1997). 
Callisaya et al (2011) conducted a prospective study investigating which gait 
variables had an association with incident falls risk. Gait variables were recorded for 
412 participants (aged 60-86) and falls were recorded prospectively over 12 months. 
Results showed variability in step length and double support time were linearly 
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associated with greater falls risk (p=0.04). A non-linear association was shown with 
gait speed (p=0.002) and cadence (p=0.004). These results show that step length, 
double support, gait speed and cadence may be useful parameters in the analysis of 
gait and help identify those at increased risk of falls. 
Restoration of gait is an important goal of rehabilitation; however little research has 
been carried out investigating gait variables in the recovery of normal gait post hip 
fracture. One study by Thingstad et al (2015) used an electronic walkway (GAITRite 
system) to identify key variables of gait and to explore how known predictors impact 
on those variables. Spatial and temporal gait parameters were collected four months 
post hip fracture in 249 participants. The results of the factor analysis showed four 
key variables as double support time, single support asymmetry, variability of step 
velocity and walk ratio. These key variables were associated with known predictors 
of poor outcome after hip fracture (cognitive decline, low grip strength, male gender) 
and warrant further assessment to confirm their importance as outcome variables in 
addition to gait speed. In-depth knowledge about gait characteristics could help to 
guide the development of more targeted and effective interventions to maximise gait 
recovery and understand the underlying mechanisms behind gait impairments in this 
population. 
 
1.9 Conclusion 
While research has shown that the TUG is a validated outcome measure to use in 
patients post hip fracture, no studies have yet investigated the use of the inertial 
sensors to provide detailed quantitative analysis of the TUG in patients post hip 
fracture. QTUG is a novel new approach to assessment of mobility and provides an 
assessment of patients’ falls risk and frailty level. In this study the QTUG will be 
used to provide an estimate of participants’ falls risk and frailty level on admission 
and discharge from a subacute rehabilitation ward and these will be compared to 
standardised clinical outcome measures. 
QTUG could also provide clinically meaningful information to therapists regarding 
which component of mobility that patients are having difficulty with and which 
aspects are being affected with therapy. QTUG will be used to analyse the time taken 
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by hip fracture patients to complete the various components of the TUG on 
admission and discharge, i.e. sit to stand, walking, turning and stand to sit. It can also 
provide information regarding changes in temporal gait parameters e.g. stride length, 
variability of stride length and double leg stance times which may serve as sensitive 
and clinically relevant parameters in the evaluation of mobility post hip fracture 
(Hausdorff, 2007). 
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CHAPTER 2: METHODOLOGY 
 
2.1  Aims and Objectives 
The primary aim of this study was to investigate the use of the QTUG in the 
assessment of hip fracture patients in a sub-acute geriatric rehabilitation setting. 
This included: 
 Investigating which components of the QTUG were sensitive to change pre 
and post rehabilitation in patients with hip fractures 
 Comparison of the Falls Risk and Frailty Level Estimates generated from 
QTUG analysis to standardised falls risk and frailty measures. 
The secondary aims of this study were:   
 Comparison of hip fracture patients’ sensor-derived QTUG parameters on 
discharge from hospital to normative data for community dwelling elderly 
population. 
 To investigate which baseline patient characteristics were associated with 
improved functional mobility on discharge from sub-acute rehabilitation post 
hip fracture. 
 
2.2  Study Design 
A descriptive prospective cohort study design was used to investigate the functional 
mobility of patients post hip fracture through the use of the QTUG on admission and 
discharge from sub-acute geriatric inpatient rehabilitation. 
The study design was developed using the Strengthening the Reporting of 
Observational studies in Epidemiology (STROBE) guidelines to ensure 
methodological validity.   
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2.3  Participants 
2.3.1  Recruitment 
A convenience sample of subjects was recruited from a 42-bed inpatient geriatric 
sub-acute rehabilitation unit.  
 
2.3.2  Inclusion/Exclusion Criteria 
Patients admitted onto the ward were transferred from two acute hospitals for further 
rehabilitation and were aged 65 or over.  
Inclusion Criteria: 
 Post hip fracture surgery  
 Mobile pre-admission to acute hospital with or without an aid (self-reported) 
 Able to complete TUG without physical assistance 
Exclusion Criteria: 
 Patients unable to provide informed consent 
 Patients unable to mobilise independently prior to admission to acute hospital 
 Severe communication difficulties and/or inability to comply with simple 
instructions (Denkinger et al, 2010) 
 
2.3.3  Sample Size 
A power calculation was conducted to estimate sample size. A sample size of 41 
participants was required to have an 80% power to detect a minimum clinically 
important difference of 3 seconds on TUG score (SD 6.9) and with an alpha of 5% 
(Brooks, 2006; Kristensen, 2011).  For this study the aim was to recruit 50 
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participants to allow for 10-20% dropout rate as has been seen in similar studies 
(Brooks et al, 2006, Van Iersel et al, 2008). 
 
2.4  Ethical Considerations  
Ethical approval was gained from Cappagh Hospital’s Research Ethics Committee in 
November 2015 (Appendices 2 and 3) and approval was then gained from Royal 
College of Surgeon’s Ireland Research Ethics Committee (Appendix 4) prior to 
commencing data collection. All data collected were stored in accordance with the 
Data Protection Act (2003) and the Data Guidance on Research in Health Sector 
(2007). Each participant was given a unique identifier code which was the only 
identifiable marker on all data sheets. These codes were stored in a separate file in a 
password protected computer which only the researchers had access to.  
All patients on the ward received usual care regardless of inclusion in the study and 
could withdraw consent at any stage. 
 
2.5  Procedure 
2.5.1  Informed Consent 
Patients who met the inclusion/exclusion criteria were approached for inclusion in 
this trial. A gatekeeper (staff physiotherapists on ward) (Appendix 5) initially 
approached the patients and provided them with the Participant Information Leaflet 
(Appendix 6). The Principal Investigator (PI) then completed the Participant Consent 
Form (Appendix 7) post 24-hour cooling off period and answered any further 
questions participants may have had. Participants were made aware of their right to 
withdraw consent at any stage. 
 
 
 
19 
 
2.5.2  Baseline Demographics: 
Participants’ baseline demographic information was obtained from medical charts by 
the PI and recorded on the data collection form (Appendix 8). Baseline data collected 
included age, gender, height, weight, number of co-morbidities, cognitive level 
(MoCA), length of stay in acute hospital, self-reported number of falls in last 12 
months, premorbid level of mobility and walking aid used if applicable. 
The type of surgery was recorded and type of fracture was recorded as cervical, 
trochanteric or sub-trochanteric as per Kristensen et al (2007). 
The New Mobility Score (Appendix 9) was used as a measure of premorbid level of 
functional mobility and has been shown to have good predictive value of functional 
outcome in patients post hip fracture (Kristensen et al, 2010a). 
 
2.5.3  Description of Rehabilitation Process 
Patients admitted onto the rehabilitation ward receive a Comprehensive Geriatric 
Assessment (CGA) from a multidisciplinary team (MDT). The MDT consisted of a 
geriatrician-led medical team, nursing, pharmacy, physiotherapy, occupational 
therapy, medical social work, dietetics and podiatry and clinical psychology as 
required. Patient-centred goal setting and discharge planning was undertaken by the 
MDT in weekly meetings. Physiotherapy assessment consisted of evaluation of 
patients’ impairments, activity limitations and participation restrictions based on the 
ICF model. Physiotherapy intervention involved individualised treatment plans 
consisting of functional transfer practice and gait re-education, lower limb and upper 
limb strengthening programs, balance exercises as well as group strengthening and 
balance classes.  
 
2.5.4  Assessment Process 
Assessment of the primary and secondary outcome measures were carried out at two 
time points; on admission to and on discharge from rehabilitation. On discharge 
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additional information was collected by the PI. This included information regarding 
participants’ length of stay, discharge destination and additional social support 
required.   
 
2.6  Primary Outcome Measure 
The primary outcome measure of the QTUG was assessed on admission and 
discharge by the PI. The process for the set-up and measurement of the QTUG 
follows the instructions as described by QTUG manufacturers (Appendix 10). The 
inertial sensors (Appendix 11) were fixed onto participants’ shanks with elasticated 
bandage. Participants began the test seated in a standard arm chair with seat height 
46cm and arm height 65cm (Podsiadlo and Richardson, 1991 and Bohannon et al, 
2006). Participants were instructed to on the word ‘Go’, rise from the chair, walk 3 
metres to the line on the floor, turn and return to sit down in the chair again. The test 
was ceased when the participant came to rest in the chair.  
Each participant underwent three timed trials of the QTUG and the fastest of the 
three was recorded. This follows guidelines set out by Kristensen et al (2010b) who 
reported that performance of the TUG improves up to and including the third trial in 
participants post hip fracture. The participants completed the falls questionnaire 
validated for QTUG (Appendix 13) and this was combined with the sensor gait 
parameters to automatically generate the falls risk estimate. The frailty estimate 
generated from the sensor gait parameters was also recorded (Figure 2.1).  
 
Figure 2.1 QTUG Falls Risk and Frailty Estimates 
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The times taken to complete the different components of the QTUG were recorded 
(sit to stand, walk time, turn time, and stand to sit). Temporal gait parameters were 
also recorded including stride length, average double support time and gait 
variability (Appendix 12). The same gait aid was used for initial and discharge 
assessments as it has been shown that gait aid impacts on performance of the TUG 
(Kristensen et al, 2009b). 
Research has shown strong inter and intra-rater reliability for standard TUG 
(Kristensen, 2011). Good to strong reliability has also been shown for the individual 
components of QTUG (McGrath et al, 2011; Greene et al, 2015 and Smith et al, 
2015). The standard TUG was also assessed in a group of 142 patients admitted to an 
orthopaedic rehabilitation unit and was found to be both a reliable and valid outcome 
measure for use in patients post hip fracture (Yeung et al, 2008). The TUG has also 
been shown to be a useful assessment tool as it does not suffer from ceiling or floor 
effects and is sensitive to change (Herman et al, 2011). A minimal clinically 
important difference (MCID) of 3 seconds on TUG time has been reported by 
Brooks et al (2006) and Kristensen et al (2011). 
 
2.7  Secondary Outcome Measures 
Secondary outcome measures were completed by the participants treating 
physiotherapists as per usual practice as timing did not allow for blinding for all 
assessments. To ensure standardisation of assessment procedures and decrease risk 
of bias training was carried out for assessment procedures among treating 
physiotherapists by PI. These measures included:   
- Tinetti Gait and Balance Assessment (Appendix 14) 
- Clinical Frailty Scale (Appendix 15) 
 
2.7.1  Tinetti Gait and Balance Assessment 
The Tinetti Gait and Balance Assessment is a 16-item tool measuring older adults 
balance and gait abilities and patients are scored out of a total of 28 points 
(Appendix 14). It has been shown to have excellent inter (ICC=0.84) and intra-rater 
reliability (ICC 0.96) in an elderly population (Thomas et al., 2005, Sterke et al., 
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2010). This scale is suitable for ortho-geriatric patients post hip fracture surgery who 
may be under post-operative hip precautions. The Tinetti Gait and Balance 
Assessment can be used to classify participants falls risk (Tinetti, 1986). A score of 
<18 indicates high risk of falling, 18-23 indicates moderate risk of falling and >23 
indicates low risk of falling. 
 
2.7.2  Clinical Frailty Scale 
The CFS is a 9 point ordinal scale ranging from a level of 1 (very fit) to 9 (terminally 
ill) based on clinical opinion (Appendix 15). Rockwood et al (2005) developed the 
CFS as an easily applicable frailty assessment tool based on clinical evaluations in 
the domains of mobility, energy, physical activity, and function. Its predictive 
validity for risk of institutionalisation and death has been shown in a 5 year 
prospective cohort study in the elderly population (Rockwood et al., 2005). It has 
also shown high inter-rater reliability (intra-class correlation coefficient (ICC) 0.97, 
p<0.01) (Rockwood et al., 2005). Frailty level of each patient was assessed on 
admission and discharge at weekly multidisciplinary team meetings based on clinical 
consensus of the team.  
 
2.7.3  Additional Outcome Measures 
Additional outcome measures carried out on admission and discharge as part of 
routine assessment by physiotherapists, occupational therapists and nursing staff on 
the ward included:  
- Elderly Mobility Scale (Appendix 16)  
- 10 metre walk test to measure gait speed (Appendix 17) 
- Grip strength (Appendix 18)  
- Euro QOL 5D (Appendix 19) 
- Barthel Index (Appendix 20) 
- Falls Efficacy Scale-International (FES-I) (Appendix 21) 
These measures were performed as part of routine care and if any issues were 
identified as part of assessment the treating medical team were informed. 
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2.8  Statistical Analysis 
Statistical Package for the Social Sciences for statistical analysis version 22.0 was 
used to analyse the data. Data were examined for normality using normal probability 
plots and the Shapiro-Wilks test. Descriptive statistics were used to describe the 
baseline demographics and assessments, with mean and standard deviation reported 
for normally distributed data and median and interquartile range reported for non-
normally distributed data.  
Significance of change pre and post rehabilitation was assessed using a paired t-test 
for parametric or Wilcoxon Signed Rank Test for non-parametric data. Correlations 
between QTUG falls risk and frailty level assessments and Tinetti and CFS were 
performed using Pearson’s correlation coefficient test for parametric data and 
Spearman rank correlation coefficient for non-parametric data. Association between 
baseline measures and discharge functional mobility was investigated using 
univariate and multivariate linear regression (Hicks, 2009 and Pallant, 2012). 
 
2.9  Resources and Costs 
There was little cost involved in the completion of this study as all equipment 
required was already available for use on the rehabilitation ward. The only costs 
included purchase of stationary and printing (approx. 50euro). 
There was little strain on staffing resources and time management to conduct study 
as outcome measures recorded are routinely performed by staff. The QTUG took a 
little extra time to perform as sensors needed to be applied to patient. The study was 
performed during routine physiotherapy service hours at Cappagh hospital. 
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CHAPTER 3: RESULTS 
 
3.1  Introduction 
The primary aim of this study was to investigate the use of the QTUG in the 
assessment of hip fracture patients in a sub-acute geriatric rehabilitation setting. 
This included: 
 Investigating which components of the QTUG were sensitive to change pre 
and post rehabilitation in patients with hip fractures 
 Comparison of the Falls Risk and Frailty Level Estimates generated from 
QTUG analysis to standardised falls risk and frailty measures. 
The secondary aims of this study were:   
 Comparison of hip fracture patients’ sensor-derived QTUG parameters on 
discharge from hospital to normative data for community dwelling elderly 
population. 
 To investigate which baseline patient characteristics were associated with 
improved functional mobility on discharge from sub-acute rehabilitation post 
hip fracture. 
3.2  Participant Flow 
Recruitment to the study took place from December 2015 to March 2016. A total 
number of 20 patients post hip fracture surgery were admitted to the rehabilitation 
unit during that time and were screened for inclusion. Out of these 16 patients met 
the inclusion/exclusion criteria and consented to participate in the study. The flow of 
participants is outlined in Figure 3.1.  
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Figure 3.1 Participant Flow Diagram 
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3.3  Baseline Demographic Data 
The mean (±SD) age of the participants was 83.1 (±6.9) years ranging from 69 to 93 
years and 75% of participants were female (n=12). All participants were admitted 
from an acute hospital with a mean (±SD) length of stay (LOS) in the acute hospital 
of 11.4 (±4.5) days. A high proportion of patients (62.5%) were independent 
mobilising at baseline without mobility aid. On admission 65% of participants 
presented with a high pre-fracture functional level (NMS Score 6-9) and 35% 
presented with a low pre-fracture functional level (NMS score 0-5).  Baseline 
demographic data is presented in Table 3.1. 
 
Table 3.1 Baseline Demographic Data 
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3.4  Clinical Profile on Admission and Discharge 
This study’s primary outcome measure was the QTUG however there were also a 
range of outcomes measured on admission to and on discharge from the unit to 
evaluate the level of patients’ impairments, activity limitations and participation 
restrictions based on the ICF model. Average LOS on the rehabilitation unit was 
45.7 days. Participants demonstrated statistically significant improvements in all 
outcome measures except hand grip. While all participants demonstrated 
improvements in mobility and function only 25% returned to their baseline level of 
mobility. The changes in outcome measures between admission and discharge are 
displayed in Table 3.2. The changes in mobility aid used at baseline, admission and 
discharge are displayed in Table 3.3. 
  
Table 3.2 Clinical Profile on Admission and Discharge 
CFS=Clinical Frailty Scale, NMS=New Mobility Scale, MoCA=Montreal Cognitive 
Assessment, FES=Falls Efficacy Scale, EMS=Elderly Mobility Scale 
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Table 3.3 Mobility Aids at baseline, admission and discharge 
 
3.5  QTUG derived parameters on admission and discharge 
To investigate the primary aim of the study, the admission and discharge QTUG data 
were analysed using paired t-tests or Wilcoxon sign-rank test. The average overall 
time taken to complete the TUG was 30.4 seconds on admission and 21.1 seconds on 
discharge with a mean difference of 9.3 seconds (95%CI 5.6 to 12.9 seconds) and a p 
value of <0.001. This demonstrates a statistically significant improvement in the 
overall TUG time between admission and discharge. The average times taken to 
complete the individual components of the TUG are displayed in Table 3.4. Each 
individual component of sit to stand time, walking time, turning time and stand to sit 
time all showed statistically significant improvements between admission and 
discharge with p values <0.05. There was also a statistically significant improvement 
for the gait parameters of double support time, percentage of double support 
variation and stride length (p<0.05). Selected gait parameters are displayed in Table 
3.5.  
Mobility Aid Baseline Admission Discharge 
Nil 62.5% (n=10) 0% (n=0) 0% (n=0) 
Walking Stick 18.75% (n=3) 0% (n=0) 43.75% (n=7) 
Crutches 6.25% (n=1) 25% (n=4) 12.5% (n=2) 
Frame 12.5% (n=2) 75% (n=12) 43.75% (n=7) 
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Table 3.4 Sensor component times for QTUG on admission and discharge 
QTUG Component 
Times 
Admission Discharge Mean 
Difference 
(95%CI) 
Significance 
P value 
1Overall TUG Time 
(s) 
30.4  
(25.8-34.9) 
21.1 
(17.1-25.1) 
9.3 
(5.6 to 12.9) 
*<0.001 
2Sit to Stand   Time 
(s) 
3.3 
(1.58) 
2.2 
(1.2) 
n/a *0.008 
2Walk Time (s) 14.0 
(5.5) 
8.2 
(4.1) 
n/a *0.003 
1Turn Time (s) 8.2 
(6.4-10.1) 
5.3 
(4.1-6.5) 
2.9 
(1.1 to 4.7) 
*0.003 
1Stand to Sit Time (s) 5.5 
(4.2-6.7) 
4.1 
(3.0-5.2) 
1.3 
(0.01 to 2.7) 
*0.049 
 *Significant at the p≤ 0.05 level. 1Normally distributed data reported as mean 
(95%Cis).   2Non-normally distributed data reported as median (IQR). 
  
Table 3.5 Sensor gait parameters for QTUG on admission and discharge 
QTUG Gait 
Parameters 
Admission Discharge Mean 
Difference 
(95%CI) 
Significance 
P value 
2Average Double 
Support Time (s) 
 
0.4 
(0.18) 
0.3 
(0.2) 
n/a *0.002 
1Double Support 
Variation (%) 
34.6 
(27.0-42.2) 
45.9 
(34.8-57.0) 
11.3 
(22.5 to 0.15) 
*0.047 
1Stride Length (m) 1.00 
(0.96-1.04) 
1.12 
(1.04-1.19) 
0.12 
(0.06 to 0.17) 
*<0.001 
*Significant at the p≤ 0.05 level. 1Normally distributed data reported as mean 
(95%Cis).   2Non-normally distributed data reported as median (IQR). 
 
The breakdown of QTUG phase times as a percentage of the overall TUG time on 
admission and discharge are represented in Figure 3.2. While each component of the 
TUG showed statistically significant improvement between admission and discharge, 
there was no change in the proportion of the overall time that each component took. 
The initial component of Sit-Stand contributed the least to the overall time with a 
proportion of 11% at admission and discharge and the Stand-Sit component took 
slightly longer contributing to 17% on admission and 19% on discharge. The time 
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taken to turn contributed to 27% of overall time on admission and 25% of overall 
time on discharge. The proportion of time spent walking contributed most to the 
overall time, with 45% of the overall time spent performing the walking component 
on admission and discharge.   
 
 
Figure 3.2 TUG Phase Times as a Percentage of Overall TUG Time 
 
3.6  Falls Risk Assessment: QTUG vs Tinetti 
A Falls Risk Estimate is automatically generated from QTUG data through 
combination of falls risk questionnaire and data derived from QTUG sensors. On 
admission the median (IQR) Falls Risk Estimate was 86.5% (14%) and on discharge 
this decreased to 69.5% (24%).  This indicates that participants improved from being 
at a high risk of falling to a moderate risk of falling. This improvement was 
significant with a p value of 0.003. 
Falls risk was also measured through the use of Tinetti Gait and Balance 
Assessment. On admission there was a mean Tinetti score of 17.9 points indicating 
high risk of falls and on discharge there was a mean Tinetti score of 22.7 points 
indicating moderate risk of falls. This supports the results of the QTUG falls risk 
assessment and indicates participants improved from being at high risk to moderate 
risk of falls. The improvement in Tinetti score was also significant with a mean 
(95%CI) improvement of 4.8 points (3.1 to 6.5) and a p value of <0.001.  
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A strong inverse correlation was shown between the two measures of falls risk both 
at admission and discharge.  On admission there was a significant inverse 
relationship between QTUG Falls Risk Estimate and Tinetti with a correlation 
coefficient of -0.673 and a significance of 0.004. On discharge they were also shown 
to be strongly correlated with a correlation coefficient of -0.764 and a significance of 
0.001 (Table 3.6). This demonstrates that the QTUG Falls Risk Estimate has a strong 
relationship with the standardised Tinetti measure. 
  
Table 3.6 Correlation between QTUG Falls Risk Estimate and Tinetti   
Correlations Correlation 
Coefficient 
Sig. (2-tailed) Intensity of 
Correlation 
Admission -0.673 **0.004 Strong Negative 
Discharge -0.764 **0.001 Strong Negative 
**Correlation is significant at the 0.05 level (2-tailed) 
 
The distribution of falls risk scores as measured by the QTUG and Tinetti on 
admission and discharge are displayed in Figures 3.3 and 3.4 below. On admission 
the QTUG Falls Risk Estimate classified 31.25% of participants as ‘very high’, 
62.5% as ‘high’ and 6.25% as ‘moderate’ risk of falling. When assessed using Tinetti 
43.75% were classified as ‘high’, 43.75% as ‘moderate’ and 12.5% as ‘low’ risk of 
falling. 
On discharge, the QTUG Falls Risk Estimate classified 12.5% of participants as 
‘very high’, 37.5% as ‘high’ and 37.5% as ‘moderate’ and 12.5% as ‘low’ risk of 
falling. When assessed using Tinetti 12.5% were classified as ‘high’, 37.5% as 
‘moderate’ and 50% as ‘low’ risk of falling. 
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Figure 3.3 QTUG Falls Risk Estimate on Admission and Discharge 
 
 
Figure 3.4 Tinetti Falls Risk Assessment on Admission and Discharge 
 
3.7  Frailty Level Assessment: QTUG vs CFS 
Frailty level was estimated from QTUG data on admission and on discharge. On 
admission the median (IQR) frailty score was 100% (0) and on discharge was 99% 
(6).  There was a statistically significant improvement between admission and 
discharge with a p value of 0.01. 
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Frailty was also measured using the CFS. On admission the median (IQR) CFS score 
was 6 (1) and on discharge was 4 (2). The CFS also demonstrated a statistically 
significant improvement between admission and discharge with a p value of <0.001.   
There were mixed results for the relationship between QTUG Frailty score and CFS 
score. On admission there was no correlation between the two measures of frailty 
whereas on discharge there was a strong positive correlation (Table 3.7). 
  
Table 3.7 Correlation between QTUG Frailty Estimate and CFS   
Correlations Correlation 
Coefficient 
Sig. (2-tailed) Intensity of 
Correlation 
Admission 0.222 0.409 Not significant 
Discharge 0.699 **0.003 Strong Positive 
**Correlation is significant at the 0.05 level (2-tailed) 
 
The distribution of frailty scores as measured by the QTUG and CFS on admission 
and discharge are displayed in Figures 3.5 and 3.6 below. On admission, 100% of 
participants were classified as ‘very frail’ by the QTUG, compared to 43.75% as 
‘severely frail’, 43.75% as ‘frail’, 6.25% as ‘transitionary’ and 6.25% as ‘vulnerable’ 
when assessed using the CFS. On discharge, 81.25% were classified as ‘very frail’, 
12.5% as ‘frail’, and 6.25% as ‘transitionary’ by the QTUG, compared to 12.5% as 
‘moderately frail’, 31.1% as ‘mildly frail’, 19% as ‘vulnerable’, 25% as ‘managing 
well’, and 12.5% as ‘well’ when assessed using the CFS. 
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Figure 3.5 QTUG Frailty Level on Admission and Discharge 
 
 
Figure 3.6 CFS Frailty Level on Admission and Discharge 
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3.8  Discharge QTUG Outcomes: Comparison to Normative Data 
On discharge from the unit the participants discharge QTUG measures were 
compared to normative data for community dwelling elderly population. The results 
are summarised in Table 3.8 below. The results showed that some of the participants 
did not return to within normal ranges for their overall TUG time, walk time, turning 
time and time spent in double stance and were within normal ranges for sit to stand, 
stand to sit, double stance variability and stride length.  
 
Table 3.8 Comparison to Normative Data for Community Dwelling Adults 
QTUG Parameter % of Participants 
within 2 SD of 
normative data 
% of Participants greater 
than 2 SD of normative 
data 
Overall TUG Time 68.8 31.2 
Sit to Stand Time 100 0 
Walk Time 75 25 
Turn Time 87.5 12.5 
Stand to Sit Time 100 0 
Double Stance Time 87.5 12.5 
Double Stance 
Variability 
100 0 
Stride Length 100 0 
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3.9  Baseline Predictors of Outcome: Regression Analysis 
Univariate regression analysis was used to assess if any of the baseline data was 
predictive of outcome in the discharge TUG score. The baseline measures 
(independent variables) of age, number of co-morbidities, falls history, type of 
fracture, type of surgery, cognitive level (MoCA) and baseline mobility level (NMS) 
were analysed for predictive value against the dependent variable of discharge TUG 
time. The results are displayed in Table 3.9.  
The number of co-morbidities and the baseline level of mobility as measured by the 
NMS were the only variables predictive of discharge TUG time. A higher number of 
co-morbidities was predictive of a higher discharge TUG time (B=2.038, p=0.038) 
and a higher level of baseline mobility NMS was predictive of a faster TUG time 
(B=-2.127, p=0.012 
 
Table 3.9 Univariate Regression to predict discharge TUG outcome 
Independent Variables Unstandardised 
Coefficients B 
Significance 
Age 0.448 0.116 
Number of Co-morbidities 2.038 *0.038 
Falls History -0.383 0.848 
Type of Fracture 0.598 0.857 
Type of Surgery -2.114 0.355 
Cognitive Level (MoCA) -0.477 0.089 
Baseline Mobility (NMS) -2.127 *0.012 
*Significant at the p<0.05 level 
 
Multivariate regression was then used on with the two independent variables of 
number of co-morbidities and baseline level of mobility that were shown to be 
predictive on univariate analysis. The results of the multivariate regression showed 
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that number of co-morbidities was no longer significant (p=0.152) but that baseline 
mobility as measured by NMS remained a significant predictor (p=0.048) of 
performance of discharge TUG (Table 3.10). 
 
Table 3.10 Multivariate Regression to predict discharge TUG outcomes 
Independent Variables Unstandardised 
Coefficients B 
Significance 
Number of Comorbidities 1.307 0.152 
Baseline Mobility (NMS) -1.672 *0.048 
*Significant at the p<0.05 level 
 
3.10  Summary of Results 
There was a statistically significant improvement in the main outcome measure of 
overall TUG time between admission and discharge of 9.3 (95% CI 5.6 to 12.9) 
seconds with a p value <0.001. Each individual time component of the TUG (sit to 
stand, walking, turning, stand to sit) also showed statistically significant 
improvements.  Time spent walking took the greatest proportion of overall time. 
There was no significant change in the proportion of overall time taken to complete 
each component between admission and discharge.  
There was a significant improvement in both falls risk and frailty level estimates 
measured using the QTUG and using clinical outcome measures of Tinetti and CFS. 
There was a strong negative correlation between the QTUG falls risk estimate and 
Tinetti scores on admission and discharge. There was no relationship between 
QTUG frailty level and CFS on admission, however there was a strong correlation 
on discharge. 
On discharge 68.8% of participants had returned to within normal ranges of 
community dwelling elderly for overall QTUG performance time. Premorbid level of 
mobility was the only significant predictor of outcome for overall QTUG time.  
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CHAPTER 4: DISCUSSION 
 
4.1  Introduction 
The results of this study demonstrated that there was a statistically significant 
improvement in overall QTUG time in participants post hip fracture in a subacute 
unit. Each individual time component of the TUG (sit to stand, walking, turning, 
stand to sit) also showed statistically significant improvements.  Time spent walking 
while performing the QTUG took the greatest proportion of the overall time. There 
was no significant change in the proportion of overall time taken to complete each 
component between admission and discharge. 
There was a significant improvement in both falls risk and frailty level estimates 
measured using the QTUG and using clinical outcome measures of Tinetti and CFS. 
There was a strong negative correlation between the QTUG falls risk estimate and 
Tinetti scores on admission and discharge. However, there was no relationship 
between QTUG frailty level and CFS on admission, however there was a strong 
correlation on discharge.  
On discharge, even though 68.8% of participants had returned to within normal 
ranges of community dwelling elderly for overall QTUG performance time; 50% of 
the participants were classified as high risk of falls and 81.25% classified as very 
frail. Premorbid level of mobility was the only significant predictor of outcome for 
overall QTUG time on multivariate analysis. 
 
4.2  Baseline Demographics 
The baseline demographics and clinical evaluations of this study’s participants were 
similar to other studies investigating the TUG in patients post hip fracture. The mean 
(±SD) age of participants in this study was 83.1 (±6.9) years which was comparable 
to the mean ages of 82.6 (Ingemarrson et al, 2003), 79.3 (Mendelsohn et al, 2003) 
and 80 years (Kristensen et al, 2009a) and the majority of participants were female 
(71 to 85%). This is also comparable to the Irish national data reported on hip 
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fractures, which reported that the majority of hip fractures occurred in the 80-89 year 
old age grouping with 73% of those being female (IHFD, 2014). 
A high proportion of participants in this study (62.5%) were independent mobilising 
at baseline without mobility aid. This baseline level of function was slightly higher 
than that reported by Kristensen et al (2009a) where 56% of participants were 
independent without mobility aid prior to fracture and higher than the figure of 54% 
reported by the IHFD in 2014. On admission 65% of participants presented with a 
high pre-fracture functional level (NMS Score 6-9) and 35% presented with a low 
pre-fracture functional level (NMS score 0-5).   
The majority of participants (68.75%) in this study presented with a cervical fracture 
(intra-capsular), with intertrochanteric fractures being the next most common (25%) 
and subtrochanteric being the least common (6.5%). This is similar to that reported 
by Kristensen et al (2009a) with the 59% presenting with cervical fractures, 39% 
with intertrochanteric fractures and 2% with subtrochanteric fractures. This differs to 
the data conveyed in the IHFD report which reported that 39% of fractures were 
cervical (intra-capsular), 39% were inter-trochanteric and 7% were subtrochanteric. 
This difference is likely due to the small sample size of this study. 
The average LOS in rehabilitation in this study was 45.7 days. This is slightly longer 
than the 6 weeks stay in sub-acute rehabilitation recommended by the National 
Clinical Care Program for the Older Person (Health Service Executive, 2012). The 
average LOS reported in similar studies for subacute hip fracture rehabilitation 
varied greatly in the literature. Freter and Fruchter (2000) reported an average LOS 
of 109 days, Hershkovitz et al (2015) reported an average of 37.5 days, Mendelsohn 
et al (2003) reported an average of 28.2 days and Kristensen et al (2009a) a median 
of 11 days. The variation in length of stay across the studies is likely due to differing 
healthcare services, availability of support and follow-up services and varying levels 
of independence on discharge. 
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4.3  Changes in QTUG parameters 
The overall outcome measure used in this study the QTUG. The QTUG was used to 
give an overall time to perform the TUG test on admission and discharge. It was also 
used to provide a breakdown of the time taken to complete the individual 
components of the TUG i.e. sit to stand time, walking time, turning time and stand to 
sit time. The data on admission and discharge were analysed to assess for amount of 
change in overall performance and in each individual component.  
 
4.3.1  Changes in Overall QTUG time 
The main outcome that was assessed was change in overall time to perform QTUG 
test. On admission the mean time to complete QTUG was 30.4 seconds and on 
discharge was 21.1 seconds. This demonstrated a mean improvement of 9.3 seconds 
(95% CI 5.6 to 12.9) and a significance p value of <0.001. This demonstrated a 31% 
improvement which was statistically and clinically significant change in QTUG time 
between admission and discharge in accordance with current literature. 
Kristensen et al (2009a) conducted a study investigated the reliability and minimal 
clinically important difference for the TUG in patients post hip fracture. They 
calculated an improvement of 11% as the standard real difference to indicate 
meaningful change for a group and 31% for individuals. The results of this study 
demonstrated a group improvement of 31% which exceeds the 11% described as 
minimal important difference indicated clinically significant improvement. Larger 
improvements in time between admission and discharge were demonstrated in a 
study by Yeung et al (2008) with a mean improvement of 40 seconds (63% 
improvement). In the study by Yeung et al (2008) the mean TUG time on admission 
was much slower (63.4 seconds) than the mean time in this study (30.4 seconds). 
This follows the findings from Kristensen et al (2009a) that those who have slower 
initial TUG times demonstrate greater improvements in time that are clinically 
significant (e.g. an MCID of 9.3 seconds for initial TUG time of 30 seconds 
compared to MCID of 18.6 seconds for initial TUG time of 60 seconds).  
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4.3.2  Changes in QTUG Components 
On analysis of the individual components of the QTUG (sit to stand time, walking 
time, turning time and stand to sit time), it was found that there was a statistically 
significant improvement between admission and discharge for each component 
(p<0.05). While each component of the TUG showed statistically significant 
improvement between admission and discharge, there was minimal change in the 
proportion of the overall time that each component took. The proportion of time 
spent walking contributed most to the overall time, with 45% of the overall time 
spent performing the walking component on admission and discharge.   
The initial component of sit-stand contributed the least to the overall time with a 
proportion of 11% at admission and discharge and the stand-sit component took 
slightly longer contributing to 17% on admission and 19% on discharge.  Sit to stand 
time was measured from the initiation of the test, the word ‘go’, to first heel contact. 
Stand to sit time was measured from the last step until the moment the participant sat 
on the chair. Stand to sit time may have taken longer than sit to stand time due to the 
participants decreased balance or fear of falling and thus being more cautious to 
control this portion of the task. Wall et al (2000) investigated the components of the 
TUG in elderly participants, those at risk of falling and compared to healthy young 
controls. They found that the elderly participants and those at risk of falling took a 
larger proportion of time to complete the stand to sit component of the task and that 
this may be a component that is useful at identifying those at higher risk of falling or 
those who are fearful of falling.  
Time spent turning was slightly more efficient on discharge compared to admission 
contributing to 25% of overall time compared to 27%. Time spent sitting back down 
in the chair was slightly less efficient on discharge contributing to 17% of overall 
time compared to 15% on admission. The increase in efficiency turning may be due 
to increased weight-bearing ability and improved turning technique post 
rehabilitation and the slight increase in proportion of time spent during stand to sit 
portion may be secondary to safety education and training received during 
rehabilitation. However due to small sample size of this study it is difficult to 
ascertain if these slight changes are clinically significant. 
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4.4  Falls Risk Assessment 
Falls risk assessment is necessary post-hip fracture and is recommended by NICE 
guidelines (2011) and the British Orthopaedic Association (2007). Many patients 
post-hip fracture go on to suffer further falls, and assessment of patients’ mobility 
levels and falls risk levels are of the utmost importance in rehabilitation units to 
prevent further falls as inpatients and on discharge (Kristensen et al, 2007). This 
study found that there was a statistically significant improvement in falls risk 
between admission and discharge when measured by both QTUG and Tinetti. 
  
4.4.1  Analysis of Falls Risk Assessment: QTUG vs Tinetti 
A Falls Risk Estimate (FRE) was automatically generated from QTUG data through 
combination of falls risk questionnaire and data derived from QTUG sensors. On 
admission the median (IQR) FRE was 86.5% (14%) and on discharge this decreased 
to 69.5% (24%).  This was a statistically significant improvement that demonstrated 
that on average participants improved from being at a high risk of falling to a 
moderate risk of falling. The FRE generated from the QTUG and the results of the 
Tinetti were shown to have a strong negative correlation both on admission and 
discharge. Participants who scored higher on the Tinetti assessment had a lower 
corresponding FRE measured by the QTUG. Both outcome measures use objective 
assessments of gait and balance parameters, therefore have shown strong correlation 
as a measure of falls risk. The FRE generated by the QTUG however tended to 
classify participants as a higher risk of falling both on admission and discharge 
compared to falls risk as classified by Tinetti. 
On discharge 50% of participants were still classified as being at least at high risk of 
falling compared to 12.5% when classified by Tinetti. One reason why QTUG may 
be classifying participants as at higher risk of falling is because the FRE is generated 
from a combination of the gait and balance parameters generated from the inertial 
sensors as well as the falls risk questionnaire. 
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4.4.2  Clinical Implications for Falls Risk Assessments 
The falls risk estimated from the QTUG compared to the Tinetti may be a more 
useful indicator of falls risk in this population as it is multi-faceted in its assessment. 
In a systematic review conducted by Barry et al (2014) investigating the standard 
TUG test, the authors concluded that the TUG test on its own may not be a useful 
indicator of falls risk as it only takes into account gait, balance and to a lesser degree 
vision and cognition. The QTUG may provide a more clinically relevant estimate of 
falls risk as the falls risk questionnaire incorporates other falls risk factors such as 
previous falls and polypharmacy in the assessment. It also uses the sensors to detect 
variations in gait pattern that may be linked with a higher risk of falls that cannot be 
assessed objectively by observation alone. These gait variations will be discussed 
further later in this chapter. 
  
4.5  Frailty Level Assessment 
The assessment of frailty is an important baseline measure and outcome tool to use 
in the rehabilitation of hip fracture patients as it can be predictive of outcome or 
further debilitation post fracture (Krishnan et al, 2013). Frailty level was shown to 
have statistically significant improvements between admission and discharge in this 
study when measured by QTUG and by CFS. Frailty level estimate when measured 
by QTUG was 100% on admission and was 99% on discharge, which classified 
participants as ‘very frail’. While this was a statistically significant improvement, a 
change of 1% in frailty level may not be deemed as clinically significant.  
Frailty was also measured using the CFS. On admission the median (IQR) CFS score 
was 6 (1) and on discharge was 4 (2). The CFS demonstrated a statistically 
significant improvement and also an improvement that would be deemed clinically 
significant as participants improved from being classified as ‘moderately frail’ on 
admission to ‘vulnerable’ on discharge.  
There were mixed results for the relationship between QTUG frailty level and CFS 
level. On admission there was no correlation between the two measures of frailty 
whereas on discharge there was a strong positive correlation. This may be due to 
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different parameters assessed by the two outcome measures in classifying frailty 
level. 
 
4.5.1  Analysis of Frailty Level Assessment: QTUG 
Frailty status measured by the QTUG was investigated by Greene et al (2014). The 
authors reported a regression based method for quantifying frailty level using QTUG 
gait parameters and Fried’s frailty phenotype. Community dwelling participants 
(n=399) were assessed to determine frailty level using Fried’s frailty phenotype 
(measured by weight loss, exhaustion, weakness, slow gait speed and low physical 
activity) and were also assessed using QTUG which generated 44-sensor derived gait 
parameters. A logistic regression model with interaction terms included was used to 
evaluate frailty, using a data set containing the sensor-derived features detailed 
above, combined with gender, age, height and weight.  
Using the QTUG inertial sensor data to predict frailty level, Greene et al (2014) 
reported that participants were classified as frail or non-frail with a mean accuracy of 
75.2% when stratified for gender. When comparing the results of this study by 
Greene et al, there are a number of differences to this current study. All participants 
in this study were classified as ‘very frail’ on admission with a median of 100% 
frailty level estimate. The participant’s baseline characteristics differed to those 
reported in the study by Greene et al. The participants in the study by Greene et al 
were all community-dwelling elderly with a mean age of 78 in those who were 
classified as frail and a mean age of 71 in those who were non-frail. This is lower 
than the mean age of 83 years for the participants in this study.  
As the QTUG regression model for predicting frailty level was generated using 
community dwelling elderly subjects, it appears to have a ceiling effect in measuring 
frailty level in the hospitalised elderly population. On admission the QTUG did not 
distinguish between frailty levels and classified all participants as ‘very frail’. On 
discharge, the QTUG frailty estimate did differentiate between some participants 
with 81.25% classified as ‘very frail’, 12.5% as ‘frail’, and 6.25% as ‘transitionary’. 
As participants were returning to community dwelling on discharge, then it may be 
more beneficial to use the QTUG as a measure of frailty at this time. 
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4.5.2  Analysis of Frailty Level Assessment: CFS 
In contrast to the QTUG frailty level assessment, the CFS is a measure of frailty 
based on clinical judgment. It is scored based on a nine-point scale and rates people 
on their functional level and disease state. For example, people may be described as 
‘moderately frail’ if they require some assistance with personal care activities, and if 
they require assistance with housework, mobilising on stairs and all outdoor 
activities. People may be classified as ‘vulnerable’ if they are independent with all 
activities, but find that symptoms limit activities e.g. fatigue.  
The CFS was developed by Rockwood et al (2005) as part of the Canadian Study of 
Health and Ageing. The study had a large sample size of 2,297 participants and both 
community dwelling and institutionalised elderly people were recruited to the study. 
The mean age of those included was approximately 83 years. The baseline 
demographics of the participants in the study by Rockwood et al. appear to be more 
comparable to the demographics of the hospitalised participants included in this 
current study as there is both community dwelling and institutionalised participants 
with a mean age of 83 years.   
This may support the use of the CFS as a baseline measure and as a measure of 
outcome in hospitalised patients post hip fracture. Frailty level as measured using the 
CFS demonstrated that patients post hip fracture improved from ‘moderately frail’ 
on admission to ‘vulnerable’ on discharge.  
 
4.5.3  Clinical Implications for Frailty Level Assessment 
In this cohort of patients in subacute rehabilitation post hip fracture, the CFS appears 
to be a more valid method of assessing frailty when compared to the QTUG. 
However, these results should be interpreted with caution. The small sample size in 
this study could be a source of bias. The CFS is also scored on clinical judgement, 
and while a multidisciplinary team was used to ascertain clinical consensus on the 
scoring, it is a subjective assessment and thus susceptible to rater bias. The CFS 
appears to have benefit in measuring for changes in frailty level during inpatient 
rehabilitation, however the QTUG does appear to demonstrate clinical utility in 
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assessing patients’ frailty level on discharge, and would have further benefit it longer 
term follow up of hip fracture patients. 
 
4.6  Gait Parameters and Comparison to Normative Values 
A consistent finding is that older people tend to develop a slower gait speed, which 
is a result of both a shorter step length and increased time spent in double limb 
stance (Oberg et al, 1993 and Bohannon et al, 1997). In addition to gait speed, gait 
variability parameters may also be indicators of increased falls risk and frailty status.   
In this study there was a statistically significant improvement for the gait parameters 
of double support time, percentage of double support variation and stride length 
(p<0.05) between admission and discharge. On discharge from the unit the 
participants discharge QTUG gait parameters were compared to normative data for 
community dwelling elderly population. The results showed that some of the 
participants did not return to within normal ranges for their overall TUG time, walk 
time, turning time and time spent in double stance and were within normal ranges for 
sit to stand, stand to sit, double stance variability and stride length.  
These variations in walking time, turning time and time spent in double stance 
support some of the findings of Thingstad et al (2015) who found that four key 
variables of double support time, single support asymmetry, variability of step 
velocity and walk ratio remained abnormal four months post hip fracture when 
measured using GAITRite walkway system. 
 
4.7  Baseline Predictors of Outcome  
Achieving independence in functional mobility is a main focus in rehabilitation post hip 
fracture and is important in returning to baseline level of functioning. Having an 
understanding of what factors impact on performance of the TUG post hip fracture can aid 
clinicians in interpreting the results of the TUG and predict outcome for patients. There are 
few studies which have published data on performance times with analyses of factors that 
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eventually could affect the TUG-performance in patients with hip fracture (Kristensen et al, 
2009a). 
In this study independent baseline variables of age, number of co-morbidities, falls history 
(number of falls in past 12 months), type of fracture, type of surgery, cognitive level and 
baseline level of mobility were analysed using univariate regression for their predictive 
ability for discharge overall TUG time. Both the number of co-morbidities and baseline level 
of mobility were found to be significant for univariate analysis, however only baseline level 
of mobility as measured by the NMS remained predictive of outcome with multivariate 
regression analysis (p=0.049).  
The findings of this study are similar to those results of Kristensen et al (2009a) who also 
reported that having a high pre-fracture level of mobility was independently associated with 
having a good TUG score under multivariate liner regression. They also found that older 
age, having an intertochanteric fracture and mobilising with a frame were predictive of a 
poorer TUG score. The study by Kristensen et al had a much larger sample size of 196 
participants compared to the small sample size of 16 participants in this study, therefore had 
s stronger power to identify statistically significant predictors of outcome.  
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4.8  Limitations of this Study 
 
 This study had a small sample size (n=16). A power calculation estimated 
that a sample size 41 participants was required to detect statistically 
significant changes in overall TUG score.  
 
 
 This study was conducted in a single-centre. The model of care in this setting 
may not reflect those of other rehabilitation units. Therefore the results may 
not be applicable to other rehabilitation centres.  
 
 
 This study investigated the QTUG in a specific cohort of hip fracture 
patients. The small sample-size and the specific inclusion criteria limit the 
generalisation of the study findings. 
 
 
 Blinding of the assessors was not possible in this study. The assessors of the 
secondary outcome measurements were also the participants treating 
therapists therefore these results may be subject to bias. 
 
 In this study all participants used walking aids while performing the QTUG, 
which may affect interpretation of the results. Previous studies using QTUG 
mostly investigate with community dwelling elderly who were independently 
mobile without aid. 
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4.9  Recommendations for Future Research 
 
 Future research should investigate the utility of the QTUG in the long term 
follow up of patients post hip fracture at 3, 6 and 12 months post hip fracture 
to determine if improvements observed in this study continue post discharge 
and to assess for presence of longer term mobility difficulties. 
 
 A larger multi-centre prospective study investigating the relationship between 
the QTUG falls risk estimate and the number of falls in the year post hip 
fracture would be beneficial in assessing the predictive ability of the QTUG’s 
falls risk estimate 
 
 
 A larger multi-centre prospective study investigating the association between 
the QTUG’s frailty level estimate on discharge and the long term outcomes 
of independent mobility and functioning and adverse events of falls, re-
admission to hospital, requiring long term care and morbidity at 12 months. 
 
 
 A larger multi-centre study would allow for more robust subgroup analysis of 
outcome post hip fracture. The QTUG could allow for meaningful analysis 
into the rehabilitation outcomes of different types of hip fracture and different 
types of surgery.  
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CONCLUSION 
Hip fractures and their management are a major challenge to our health care system 
and to our society. Hip fractures are considered the most significant fragility fracture 
in the elderly and many do not return to their premorbid level of function. 
Assessment of patients’ mobility levels, frailty levels and falls risk are of the utmost 
importance in rehabilitation units. This study used the QTUG a novel new approach 
in the assessment of mobility post hip fracture and provided a new method of 
assessment of patients’ falls risk and frailty levels. 
In this study patients post hip fracture demonstrated a statistically significant 
improvement in overall QTUG time between admission and discharge in a subacute 
unit. The use of the QTUG allowed for analysis of the individual component tasks of 
the TUG. Each individual time component of the QTUG (sit to stand, walking, 
turning, stand to sit) showed statistically significant improvements.  Time spent 
walking while performing the QTUG took the greatest proportion of the overall time. 
There was no significant change in the proportion of overall time taken to complete 
each component between admission and discharge. 
The QTUG also provided a new method of assessing patients’ falls risk and frailty 
levels and these were compared to the traditionally used outcome measures of Tinetti 
and CFS. There was a strong relationship found between the QTUG falls risk and 
Tinetti falls risk estimates. The QTUG falls risk assessment seems to have additional 
benefit as it also takes into multifactorial falls risk factors as well as gait and balance 
factors. Further research investigating the relationship between the QTUG falls risk 
estimate and the number of falls in the year post hip fracture would be beneficial in 
assessing the predictive ability of the QTUG’s falls risk estimate 
The QTUG frailty estimate did not have a correlation with CFS and did not 
distinguish between patients’ in terms of frailty level on admission to the unit. 
However the QTUG does appear to demonstrate clinical utility in assessing patients’ 
frailty level at a higher functioning level on discharge, and would have further 
benefit it longer term follow up of hip fracture patients.  
The QTUG was also beneficial in assessing patients gait parameters in relation to 
normative values for community dwelling elderly population. This data can be used 
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to identify participants who are higher risk and may require further input on 
discharge from hospital to return to premorbid level of functioning. Further research 
using the QTUG for long term follow up would provide clinically meaningful 
information into the outcomes of hip fracture patients in Ireland. 
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Table of ICC values (Greene et al, 2015): 53 parameters 
TABLE II: INTRACLASS CORRELATION COEFFICIENTS 
(ICC(2,K)) FOR MOBILITY PARAMETERS.  
ICC (2,k)  
(95% CI)  
ICC (2,k)  
(95% CI)  
Inertial sensor parameter MS  Control       
Mean Z-axis ang. vel. x Height (deg.m/s)  0.98 (0.97-0.99)  0.83 (0.69-0.91)  
Mean Z-axis ang. vel. (deg/s)  0.98 (0.97-0.99)  0.83 (0.70-0.91)  
Mean X-axis ang. vel. × Height (deg.m/s)  0.98 (0.97-0.99)  0.86 (0.75-0.93(  
TUG test time (s)*  0.98 (0.97-0.99)  0.67 (0.41-0.82)  
Mean X-axis ang. vel. (deg/s)  0.98 (0.960.99)  0.86 (0.75-0.93)  
Mean Y-axis ang. vel. (deg/s)  0.96 (0.94-0.98)  0.85 (0.74-0.92)  
Mean Y-axis ang. vel. × Height (deg.m/s)  0.96 (0.93-0.98)  0.84 (0.72-0.92)  
Walk time (s)  0.96 (0.93-0.98)  0.94 (0.89-0.97)  
Mean stride length (cm/s)  0.95 (0.92-0.97)  0.95 (0.91-0.97)  
Magnitude mean at mid-swing points (deg/s)  0.94 (0.90-0.97)  0.95 (0.91-0.97)  
CV X-axis ang. vel. (%)  0.93 (0.89-0.96)  0.87 (0.76-0.93)  
Turn mid-point time (s)  0.93 (0.89-0.96)  0.89 (0.80-0.94)  
Min Z-axis ang. vel. (deg/s)  0.93 (0.89-0.96)  0.85 (0.73-0.92)  
Min Z-axis ang. vel. x Height (deg.m/s)  0.93 (0.88-0.96)  0.83 (0.70-0.91)  
Min Y-axis ang. vel. × Height (deg.m/s)  0.92 (0.87-0.96)  0.94 (0.90-0.97)  
Max X-axis ang. vel. × Height (deg.m/s)  0.92 (0.87-0.96)  0.88 (0.79-0.94)  
Return from turn time (s)  0.92(0.87-0.96)  0.91 (0.85-0.95)  
Number of steps  0.92 (0.86-0.95)  0.93 (0.87-0.96)  
Max X-axis ang. vel. (deg/s)  0.92 (0.86-0.95)  0.89 (0.80-0.94)  
Min Y-axis ang. vel. (deg/s)  0.92 (0.86-0.95)  0.95 (0.90-0.97)  
Min X-axis ang. vel. × Height (deg.m/s)  0.90 (0.84-0.95)  0.84 (0.71-0.91)  
Number of gait cycles  0.90 (0.83-0.95)  0.91 (0.85-0.95)  
Min X-axis ang. vel. (deg/s)  0.90 (0.82-0.94)  0.84 (0.71-0.92)  
CV Y-axis ang. vel. (%)  0.88 (0.80-0.94)  0.89 (0.81-0.94)  
Max Y-axis ang. vel. × Height (deg.m/s)  0.88 (0.79-0.93)  0.96 (0.92-0.98)  
CV Z-axis ang. vel. (%)  0.88 (0.79-0.93)  0.89 (0.81-0.94)  
Max Y-axis ang. vel. (deg/s)  0.87 (0.78-0.93)  0.96 (0.93-0.98)  
Mean stride time (s)  0.86 (0.76-0.92)  0.94 (0.90-0.97)  
Cadence (steps/min)  0.85 (0.74-0.92)  0.90 (0.83-0.95)  
Mean stride velocity (cm/s)  0.85 (0.74-0.91)  0.92 (0.85-0.96)  
Mean step time (s)  0.85 (0.74-0.91)  0.94 (0.88-0.97)  
Mean swing time (s)  0.80 (0.67-0.89)  0.94 (0.88-0.97)  
Max Z-axis ang. vel. x Height (deg.m/s)  0.75 (0.57-0.86)  0.77 (0.58-0.88)  
Max Z-axis ang. vel. (deg/s)  0.74 (0.56-0.86)  0.77 (0.59-0.88)  
CV stride length (%)  0.72 (0.52-0.84)  0.94 (0.89-0.97)  
Double support variability (%)  0.69 (0.47-0.83)  0.53 (0.16-0.75)  
Magnitude range at mid-swing points (deg/s)  0.68 (0.45-0.82)  0.82 (0.68-0.90)  
Stride time variability (%)  0.66 (0.42-0.81)  0.58 (0.24-0.78)  
CV stride velocity (%)  0.62 (0.35-0.79)  0.75 (0.55-0.87)  
Swing time variability (%)  0.61 (0.34-0.78)  0.48 (0.08-0.73)  
Turning time (s)  0.59 (0.30-0.77)  0.79 (0.63-0.89)  
Mean stance time (s)  0.58 (0.29-0.77)  0.90 (0.82-0.95)  
Mean single support (%)  0.48 (0.11-0.71)  0.92 (0.85-0.96)  
Number of strides in turn  0.44 (0.05-0.69)  0.58 (0.25-0.78)  
Walk ratio  0.38 (0.00-0.65)  0.81 (0.67-0.90)  
Ratio strides/turning time  0.36 0.00-0.64)  0.59 (0.26-0.78)  
Turn magnitude (deg/s)  0.34 (0.00-0.63)  0.40 (0.00-0.68)  
Mean double support (%)  0.33 (0.00-0.63)  0.83 (0.69-0.91)  
Step time variability (%)  0.33 (0.00-0.63)  0.42 (0.00-0.69)  
Single support variability (%)  0.32 (0.00-0.62)  0.43 (0.00-0.70)  
Stance time variability (%)  0.27 (0.00-0.60)  0.70 (0.46-0.84)  
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Table of ICC values (Smith et al, 2016): 21 parameters 
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APPENDIX 2: ETHICS APPLICATION FORM 
1. Title of the Research Project: 
Quantitative Analysis of the Timed Up and Go in elderly patients post hip 
fracture in a sub-acute rehabilitation setting 
1. Is this study a clinical trial of a medicine or a clinical investigation of a 
medical device? No 
If No, please delete Box A and move to Box B.  If yes, and your trial relates to 
medicinal products for human use, please do not use this application form.  
Please fill in the standard Department of Health and Children Application 
Form:  
http://www.dohc.ie/issues/clinical_trials_2004/forms.doc 
Box B: 
Is Cappagh National Orthopaedic Hospital the only site in which it is proposed that 
this research will take place? Yes 
Is this a multi-centre study?    No 
 
2.  Principal Investigator:   The person who takes primary responsibility for the 
conduct of the research. 
For research involving patients, it is essential that a Cappagh National 
Orthopaedic Hospital Consultant be named as a co-investigator. 
Name: Present 
Appointment: 
Title:  (Dr. / 
Mr. / Ms) 
Qualifications 
Grace Coakley Basic Grade 
Physiotherapist 
Ms BSc (Hons) Physiotherapy 
MISCP 
Address: Direct Telephone 
No. 
Mobile E-Mail 
Physiotherapy 
Department, 
Cappagh 
National 
Orthopaedic 
Hospital, Finglas, 
Dublin 11 
01 803 0419 083 4774007 grace.coakley@cappagh.ie 
 
Other Investigators (details of each Co-Investigator) 
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Qualifications 
Dara Meldrum Lecturer Royal 
College of 
Surgeons in 
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Dr. BSc. (Physio), MSc. 
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PhD, MISCP 
Address: Direct Telephone 
No. 
Mobile E-Mail 
Royal College of 
Surgeons in 
Ireland, School of 
Physiotherapy,  
123 St Stephens 
Green, Dublin 2 
01 4022368  dmeldrum@rcsi.ie 
Other Investigators (details of each Co-Investigator) 
Name: Present 
Appointment: 
Title:  (Dr. / Mr. 
/ Ms) 
Qualifications 
    
Address: Direct Telephone 
No. 
Mobile E-Mail 
    
 
Other Investigators (details of each Co-Investigator) 
Name: Present 
Appointment: 
Title:  (Dr. / Mr. 
/ Ms) 
Qualifications 
    
Address: Direct Telephone 
No. 
Mobile E-Mail 
    
 
3.  Please indicate whether any payments, monetary or otherwise, are to be 
made to a person for conducting this research project or any part of the project.  
No payments, monetary or otherwise are being made to a person for conducting this 
research. Future funding may be sought from the chartered physiotherapists in 
neurology and gerontology clinical interest group of the Irish Society of Chartered 
Physiotherapists. 
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Do not leave any question unanswered.  As far as possible, type an answer to 
each question and do not use ‘non-applicable’ or ‘as above.’  
It is important that the language used in this application is clear and 
understandable to lay members.  Do not use acronyms. 
 
DETAILS OF THE RESEARCH PROJECT                                                                                                  
4 (a) Has this or a similar application been previously submitted for review to this or 
any other Ethics Committee in Ireland or the EU and, if so, what was the outcome? 
 No 
 
4 (b) Has similar research on this topic been done before in this country or 
elsewhere? Yes 
5 
Proposed Commencement Date: September 2015 
Proposed Duration: Years 0 Months 7 
Proposed Completion Date:  March 2016 
 
6 (a) What is the principal research objective of the proposed study?  
The primary aim of this study is to investigate the use of inertial sensors in the 
quantitative assessment of hip fracture patients in a sub-acute geriatric rehabilitation 
setting. 
6 (b) What are the secondary research objectives?  
The secondary aims of this study are: 
To investigate which components of the ‘Timed Up and Go’ show the greatest 
change pre and post rehabilitation in patients with hip fractures 
To investigate which phase of the ‘Timed Up and Go’ has the greatest impact on 
overall performance time in patients post hip fracture 
To investigate which baseline patient characteristics are associated with improved 
functional mobility on discharge from sub-acute rehabilitation post hip fracture 
 
6 (c) What is the scientific justification for this research? 
Hip fracture is an increasing public health issue due to our ageing population. Every 
year over 3000 people are hospitalised with hip fracture resulting in high healthcare 
costs of 35 million euro (Irish Hip Fracture Database 2013). Hip fractures are 
associated with high rates of morbidity and mortality. Approximately 10% of people 
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with hip fracture die within one month and one third within one year (NICE 
guidelines, 2011).   
Hip fracture as a result of falls has been related to mobility and balance impairments, 
osteoporosis, visual and other health problems (Dargent-Molina et al, 1996 and 
Kristensen et al, 2007). Furthermore, 12% of patients with hip fracture go on to 
suffer a second hip fracture with a significant decline in their mobility and 
independence (Pearse et al, 2003). Many patients do not regain premorbid level of 
mobility and function (Rosell et al, 2003 and Stenvall et al, 2005). Kristensen et al 
(2009a) describes regaining basic functional mobility as the first key step in 
returning to premorbid level of functioning.  
Functional outcome measures are used in rehabilitation to establish a baseline 
description, screen for risk factors or undetected problems, assist in diagnosis, set 
therapeutic goals and monitor patients’ clinical progress (Mendelsohn et al, 2003). 
The ‘Timed Up and Go’ (TUG) is a test of functional mobility that measures the 
time in seconds that it takes a person to rise from a chair, walk 3 metres, turn and sit 
down in the chair again (Podsiadlo and Richardson, 1991).  The TUG is a test that 
can be used to quantify basic functional mobility in patients post hip fracture as well 
as for evaluating clinical change over time (Ingemarsson et al, 2003). 
While research has shown that the TUG is a validated outcome measure to use in 
patients post hip fracture, no studies have yet investigated the use of the inertial 
sensors to provide detailed quantitative analysis of the TUG in patients post hip 
fracture. Quantitative analysis of the TUG could provide clinically meaningful 
information to therapists regarding which component of functional mobility that 
patients are having difficulty with and which aspects are being affected with therapy. 
It can also provide information regarding changes in temporal gait parameters e.g. 
step length, stride length, variability of stride length and stance times which may 
serve as sensitive and clinically relevant parameters in the evaluation of mobility 
post hip fracture (Hausdorff, 2007). 
  
7.  Give a full summary of the purpose, design and methodology of the planned 
research, including explanation of the theoretical framework that informs it.  Is 
should be clear exactly what will happen to the participant, how many times 
and in what order. 
 
Purpose and Design 
A prospective cohort study design is proposed to investigate the functional mobility 
of patients post hip fracture through the use of the QTUG on admission and 
discharge from sub-acute geriatric inpatient rehabilitation. 
The main purpose of this study is to investigate the gait parameters of patients post 
hip fracture pre and post rehabilitation and to assess for the amount of change. 
Having further knowledge regarding the aspects of mobility affected in patients post 
hip fracture will also inform therapists and help to target therapy interventions. 
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Methodology 
A convenience sample of subjects will be recruited from the active rehabilitation 
unit. 
Inclusion Criteria: 
Post hip fracture surgery  
Mobile pre-admission to acute hospital with or without an aid (self-reported) 
Able to complete TUG without physical assistance 
Exclusion Criteria: 
Patients unable to provide informed consent 
Patients unable to mobilise independently prior to admission to acute hospital 
Severe communication difficulties and/or inability to comply with simple 
instructions (Denkinger et al, 2010) 
Patients who meet the inclusion/exclusion criteria will be approached for inclusion in 
this trial. A gatekeeper (basic grade physiotherapist on ward) will approach the 
patients and provide them with the Participant Information Leaflet. The Principal 
Investigator (PI) will then complete the Participant Consent Form post 24 hour 
cooling off period and will answer any further questions participants may have. 
Participants will be made aware of their right to withdraw consent at any stage. 
Participants’ baseline demographic information will be obtained from medical charts 
and routine initial assessment by PI and recorded on the data collection form. 
Baseline data to be collected will include age, gender, height, weight, number of co-
morbidities, length of stay in acute hospital, self-reported number of falls in last 12 
months, premorbid level of mobility and living situation. Type of surgery will be 
recorded and type of fracture will be recorded as cervical, trochanteric or sub-
trochanteric. New Mobility Score will be used as a measure of premorbid level of 
functional mobility and has been shown to have good predictive value of functional 
outcome in patients post hip fracture. 
Primary Outcome Measure: 
The primary outcome measure of the QTUG will be assessed on admission and 
discharge by the primary investigator. The process for the set-up and measurement 
of the QTUG follows the instructions as described by QTUG manufacturers. The 
inertial sensors will be fixed onto participants shanks with elasticated bandage. 
Participants begin the test seated in a standard arm chair with seat height 46cm and 
arm height 65cm. Participants will be instructed to on the word ‘Go’, rise from the 
chair, walk 3 metres to the line on the floor, turn and return to sit down in the chair 
again. The test will be ceased when the participant comes to rest in the chair.  
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Each participant will undergo three timed trials of the QTUG and the fastest of the 
three will be recorded. This follows guidelines set out by Kristensen et al (2010b) 
who reported that performance of the TUG improves up to and including the third 
trial in participants post hip fracture. The time taken to complete each component of 
the QTUG will be recorded (sit to stand, walk time, turn time, stand to sit). Temporal 
gait parameters will also be recorded. The same gait aid will be used for initial and 
discharge assessments. 
Secondary Outcome Measures: 
Secondary outcome measures will be completed by the participants treating 
physiotherapists as per usual practice as timing will not allow for blinding for all 
assessments. To ensure standardisation of assessment procedures and decrease risk 
of bias training will be carried out for assessment procedures among treating 
physiotherapists by PI. These measures include:   
Elderly Mobility Scale  
10 metre walk test will be used to measure gait speed  
Grip strength will be measured using a BASELINE Hand Dynamometer  
Tinetti Gait and Balance Assessment  
EuroQoL 5D  
Additional outcome measures carried out on admission and discharge as part of 
routine assessment by occupational therapists on the ward include:  
Barthel Index  
Falls Efficacy Scale-International (FES-I)  
Montreal Cognitive Assessment (MOCA)  
Frailty level of each patients is assessed on admission and discharge using the 
Clinical Frailty Scale at weekly multidisciplinary team meetings. The Clinical Frailty 
Scale was developed as an easily applicable frailty assessment tool based on clinical 
evaluation in the domains of mobility, energy, physical activity and function. 
These measures are performed as part of routine care and if any issues are identified 
as part of assessment the treating medical team will be informed. 
Discharge outcomes: 
On discharge additional information will be collected by the PI. This will include 
information regarding participants’ length of stay, discharge destination, additional 
social support required. Data regarding outcome measure and amount of therapy 
undergone will be collated by PI on discharge from an existing computer program 
already in use by treating physiotherapists and occupational therapists. This data will 
include overall therapy time, number of therapy and type of therapy with 
physiotherapists and occupational therapists. To minimise recall bias with collecting 
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this data, therapists will be encouraged to enter these statistics to the program as 
soon as possible. 
 
8(a) Does the design of the study allow a statistically significant conclusion to be 
reached? Yes 
8(b) What method(s) of analysis will be used? 
Data will be examined for normality using normal probability plots and the Shapiro-
Wilks test. Descriptive statistics will be used to describe the baseline demographics 
and assessments. Significance of change will be assessed using a paired t-test for 
parametric or Wilcoxon Signed Rank Test for non-parametric data. Comparison of 
discharge data with normative data of community dwelling elderly will be performed 
using independent samples t-tests (parametric) or Mann-Whitney tests (non-
parametric). Association between baseline measures and discharge functional 
mobility will be investigated using Pearson’s test for parametric or Spearman’s for 
non-parametric data. 
9.  Please name the medical device that it is proposed to investigate in the course 
of the study?  (ONLY RESPOND TO THIS QUESTION IF YOU 
RESPONDED TO BOX A, Question 1) 
10(a)  State all possible risks to be incurred by PARTICIPANTS in the 
proposed clinical trial or research study?  
Nature of 
Risk: 
 
Probability of 
Risk: 
 
Magnitude of 
Risk: 
 
Physical / 
Psychological/Psychosocial 
or other 
(e.g bruising 
due to blood 
sample) 
(e.g. Very High 
Risk) 
(e.g. not serious) (e.g. physical) 
Fall Very low risk Serious Physical 
 
 
10(b) State all possible risks to be incurred by CONTROLS in the proposed 
clinical trial or research study? 
There are no control subjects in this study.  
 
11(a) Please list those procedures in the study to which SUBJECTS will be 
exposed indicating those which will be part of Normal care and those that will 
be Additional.  (If your participants are staff members, normal is the normal 
working day, additional is your research i.e. questionnaires, interviews and focus 
groups.) 
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Normal Care: Additional Care: 
Physiotherapy assessment of TUG using 
inertial sensors 
Physiotherapy Assessment of physical 
function on admission and discharge. 
Physiotherapy treatment interventions 
Medical assessment of depression 
Occupational therapy assessment and 
treatment interventions 
Assessment of Quality of Life on 
admission and discharge 
  
 
11(b) Please list those procedures in the study to which CONTROLS will be 
exposed indicating those which will be part of Normal care and those that will 
be Additional.  There are no control subjects in this study. 
 
12.  Please indicate if any treatment is withheld as a result of taking part in the 
study.  
No treatment is being withheld as a result of taking part in this study. 
 
13(a) What is the potential for pain, discomfort, distress, inconvenience or 
change to lifestyle for RESEARCH PARTICIPANTS? 
 
Pain (e.g. skin 
biopsy, lumbar 
puncture): 
Discomfort (e.g. 
while giving a 
blood sample): 
Inconvenience 
(e.g. attending a 
clinic/filling in a 
questionnaire): 
Change to lifestyle 
(e.g. results of 
genetic testing / risk 
of surgery 
impacting on 
participant 
lifestyle: 
There is no 
potential for pain 
in this study 
There is no 
potential for 
discomfort in this 
study  
There will be no 
inconvenience as 
all measures are 
taken as part of 
routine care 
No negative changes 
to lifestyle are 
anticipated. 
13(b) What is the potential for pain, discomfort, distress, inconvenience or 
change to lifestyle for CONTROLS?  
There are no control subjects in this study. 
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14. (a) What is the potential for benefit for RESEARCH PARTICIPANTS who 
agree to take part in this research, if any?  
This study is hoping to establish what changes happen to patients gait parameters 
and what components of functional mobility improve with rehabilitation. This study 
will not affect the care participants receive whilst and inpatient in Cappagh Hospital. 
14 (b) What is the potential for benefit for CONTROLS who agree to take part 
in this research, if any?  
There are no control subjects in this study.  
 
15(a) How will the health of the participants be monitored both during and after the 
study?   
The participants will be under Nursing and Medical care provided by Cappagh 
National Orthopaedic Hospital at all times during and after this study.  
 
15 (b) What criteria exist for withdrawing individual participants prematurely?  
A participant may withdraw at any time without giving reason. If a subject decides 
not to participate, or withdraws, their  rehabilitation will not be affected in anyway. 
This will be clearly stated to the patient.  
15 (c) What steps will be followed if participants decide to withdraw during the 
course of the study?  
Participants who withdraw from the study will have all identifiable data destroyed. 
None of their data will be used in the final research project. 
16. What criteria exist for stopping or prematurely ending the research study?  
If the medical team feels it is necessary, they may stop a subject’s participation in the 
study at any time without participant consent. 
 
17. (a) What arrangements are in place for monitoring, recording and reporting 
and evaluating adverse events? Please state who has overall responsibility in 
this area and what protocols are in place to monitor any unforeseen events.  
(Please name the person with overall responsibility.) 
The participant will be under the care of the medical, nursing and multi-disciplinary 
team at all times whilst an inpatient in Cappagh Hospital. If any adverse events occur 
the relevant and appropriate medical, nursing and multi-disciplinary team members 
will be informed, incident report forms will be filled out and the relevant action will 
take place as per standard hospital policy. It is the responsibility of the principle 
investigator, Grace Coakley, to report immediately in writing to the Research Ethics 
Committee. 
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17. (b) Will a data monitoring committee be convened? No 
If Yes, please give details. 
 
18. Does the Principal Investigator or any of the key investigators have any 
direct or indirect involvement in the outcome of the study that could in any way 
be regarded as a conflict of interest? 
The principal investigator may also be at times the participants treating 
physiotherapist. This may introduce and element of bias in the results however this is 
unavoidable due to current staffing levels. Participation or non-participation will not 
affect the standard of care that the participant will receive. This is clearly stated in 
the participation information leaflet. 
 
 
Details of Participants 
 
19. How many Subjects and Controls are expected to participate at each named 
site? 
Principal 
Investigator: 
Site: Number of 
Subjects: 
Number of 
Controls: 
Grace Coakley Cappagh National 
Orthopaedic 
Hospital 
41 0 
  Total:  41 Total:  0 
 
20. (a) How will Subjects be identified, approached, recruited and selected?  (Please 
be clear on whether you are approaching subjects in person in a clinic / on a ward, or 
in writing via letter at home, and how you are identifying patients e.g. from clinic 
lists etc.  Also, be clear on how you are recruiting e.g. by poster, by website 
advertisement.) 
Identified Approached  Selected Recruited 
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Consecutive 
sampling of 
patients admitted 
to Active 
Rehabilitation 
Unit post hip 
fracture  
The Gatekeeper will 
present a Participant 
Information Leaflet 
and answer any 
questions a potential 
participant may have. 
The PI will be 
available for further 
questions after this 
point. 
Inclusion Criteria: 
Patients admitted to 
the Active 
Rehabilitation Unit 
post hip fracture 
A Participant 
Information leaflet 
and a signed 
Consent form will 
be obtained. 
 
 
20 (b) How will Controls be identified, approached, and recruited and selected?  
There are no controls in this study 
21.  What are the principal inclusion criteria?  (Please be careful not to contradict 
your replies to Question 29) 
1 Post hip fracture surgery  
Mobile pre-admission to acute hospital with or without an 
aid (self-reported) 
 
Able to complete TUG without physical assistance 
 
22.   What are the principal exclusion criteria?   (Please be careful not to 
contradict your replies to Question 29) 
1 Patients who do not consent to study 
participation 
2 Inability to mobilise pre-admission 
to the acute hospital 
3 Severe communication problems 
4 Inability to comply with simple 
instructions 
 
23. Will any of the participants be simultaneously involved in any other 
research investigation?                                                                       No, not to my 
knowledge. 
 
24. Will participants receive reimbursement of expenses (travel costs, loss of 
earnings) or any other incentive or benefits for taking part in this research?  
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No,as there are no anticipated travel expenses. 
 
25 (a) Will the participant’s family Doctor be notified of the proposed study? 
  No 
25(b) Does the Information Leaflet inform the participant that their GP will be 
contacted?     No 
25(c) Have you included a copy of the letter to the General Practitioner for 
review? No 
 
PATIENT INFORMED CONSENT 
 
26 (a) Will written informed consent be obtained? Yes 
26 (b) Have you enclosed a copy of the Consent Form for Review? Yes 
26 (c) Which named person(s) will be responsible for obtaining consent? 
(qualifications and experience) 
 Name: Qualification Experience 
1 Grace Coakley BSc Hons Physiotherapy 4 years clinical 
experience 
 
26 (c) Give details of how this will be done.  (Be careful to ensure your replies are 
consistent with Questions 20 (a) and 20 (b))  
Patients who meet the inclusion/exclusion criteria will be approached for inclusion in 
this trial. A gatekeeper (basic grade physiotherapist on ward) (Appendix 2) will 
approach the patients and provide them with the Participant Information Leaflet 
(Appendix 3). The Principal Investigator (PI) will then complete the Participant 
Consent Form (Appendix 4) post 24 hour cooling off period and will answer any 
further questions participants may have. Participants will be made aware of their 
right to withdraw consent at any stage. 
 
27 (a) Will the participants be provided with an Information Sheet and Consent 
Form? 
Yes 
27 (b) Will the controls be provided with an Information Sheet and Consent 
Form?   
No, there are no controls in this study. 
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28. Will the participant be given as much time as they require in which to make 
a decision regarding participation in this research study?  Yes 
29(a) Are any of the following groups included: 
Pregnant Women  No 
Women of Child bearing potential  No 
Children or Minors (≤16 years)1  No 
Cognitively impaired persons2 Yes  
Comatose patients  No 
Elderly/aged persons (> 65 years) Yes  
Hospital Employees3  No 
Students in the Hospital e.g. NCHD students4  No 
 
29 (b) If so, please justify outlining how the study is expected to benefit the 
individual who participates. 
Risk Group to be included in the study: Benefit to individuals in that risk group: 
Cognitively impaired persons and 
Elderly/aged persons 
This study will establish what aspects of 
mobility are impaired post hip fracture, 
thus providing valuable information to 
provide further focus to therapy 
interventions 
 
 
 
 
29 (c) State the manner in which consent will be obtained paying particular 
attention to the role of parents, legal representatives, witness etc  
                                                     
1 Parts 4 and 5 of Schedule 1of the European Communities (Clinical Trials on Medicinal Products for Human 
Use) Regulations 2004 clearly outlines conditions and principles which apply in relation to treatment of Minors 
who are participants in medical research. 
2 Parts 4 and 5 of Schedule 1of the European Communities (Clinical Trials on Medicinal Products for Human 
Use) Regulations 2004 clearly outlines conditions and principles which apply in relation to treatment of 
Incapacitated Adults who are participants in medical research. 
3 Hospital staff are excluded from participating in Cappagh National Orthopaedic Hospital studies, where a 
supervisory or dependent relationship exists with the Principal Investigator or any of the co-investigators listed in 
response to Question 2.  
4 Medical Students and NCHDs are excluded on ethical grounds from participating in Cappagh National 
Orthopaedic Hospital studies.   
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Minors & the role of 
parents /guardians:  
Adults without capacity and 
the role of legal 
representatives:  
Will the consent form 
include a witness signature?  
No minors will be 
included in this study 
No adults without capacity 
will be included in this study 
Yes, Grace Coakley, the 
principle investigators 
signature 
 
30(a) Does the Research involve the COLLECTION of human biological material?
  No 
30(b) Does the Research involve the RETENTION of human  biological material? 
No 
30(c) Who is the custodian of this human biological material? There is no human 
biological material involved in this study 
 
30 (d) Does a recognised protocol exist for the collection, storage, care and 
disposal of this material? No as there is no human biological material involved in 
this study 
30 (e)  Have you enclosed a separate Consent Form for the Retention of Human 
Tissue for review? No as there is no human biological material involved in this 
study 
30 (f)  Does your research involve GENETIC TESTING? No 
30 (g) Have you enclosed a separate Consent Form for Genetic Testing for 
review? No as genetic testing is not involved in this research 
30 (h) Are arrangements in place for destroying identifiable samples to prevent 
further analysis should consent be withdrawn at a later time? No as genetic 
testing is not involved in this research 
30 (i) Are samples sent outside of Cappagh National Orthopaedic Hospital?
 No 
31. What arrangements exist to ensure participants are informed of any new 
information that becomes available during the course of the study? 
(Particularly information that could impact on their initial consent.) 
All results of assessments will be given and explained to the participants. As this is 
an observational study, it is not anticipated that new information that will impact on 
their initial consent will become available. 
32 (a) How will the results of this study be reported and disseminated?  
This research protocol forms part of a Masters Degree in Neurology and 
Gerontology and will be reported in a thesis by the principle investigator. 
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32 (b) Will results be made available to research participants? Yes 
If so, how will this be done? It is part of routine physiotherapy practice to inform 
the client of their results. 
INDEMNITY  
33. What arrangements have been made to provide indemnification and/or 
compensation in the event of a claim by, or on behalf of, a participant for 
negligent harm?  
The Principal Investigator is an employee of Cappagh National Orthopaedic Hospital 
and is covered by the hospitals Clinical Indemnity scheme. 
34. What arrangements have been made to provide indemnification and/or 
compensation in the event of a claim by, or on behalf of, a participant for non- 
negligent harm? 
The Principal Investigator is an employee of Cappagh National Orthopaedic Hospital 
and is covered by the hospitals Clinical Indemnity scheme. 
35 (a) Have all medical practitioners involved in this study current medical 
malpractice insurance? Yes 
35 (b) Is each member of the investigative team insured? Yes 
CONFIDENTIALITY 
36 (a) Who is the custodian of the data generated?   
The principal investigator, Grace Coakley, is the custodian of the data generated. 
36 (b) Who has access to this data? 
  Hospital Employee? 
1 Grace Coakley Yes  
2    
3    
 
36 (c) Does the Information Leaflet inform participants who is going to have 
access to their data? Yes 
36 (d) How is security of data maintained?  
Data will be encrypted using a software package.  Electronic data will be password 
protected (changed regularly) and will be stored in Cappagh Hospitals physiotherapy 
department. All written data will be stored in a locked cabinet with access restricted 
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to the PI. To uphold participant confidentiality, unique identifier codes will be used 
to conceal personal details and will not be disclosed except to persons involved in 
the study.  
37 (a) How will the data be stored AND for how long?  
Electronic data will be password protected which will be changed regularly and will 
be stored in Cappagh Hospitals physiotherapy department. Data will be encrypted 
using software. All written data will be stored in a locked cabinet with access 
restricted to the PI. Coded data will be stored securely for five years 
37 (b) How will the data be disposed of?  Paper data will be shredded and 
electronic data destroyed 
37 (c) Does the Information Leaflet inform participants how long data will be 
stored for, and how data will be destroyed:  Yes 
38 (a)What action will be taken to ensure that the identity of each participant 
remains confidential?  
To uphold participant confidentiality, number codes will be used to conceal personal 
details and will not be disclosed except to persons involved in the study.  
38 (b) Would you class the data as anonymous, identifiable or coded?   
The data will be coded 
39 (a) Will the participant’s medical records be examined? Yes 
39 (b) Will any medical records be examined by research workers? Yes 
If Yes, please justify.  
Current medical information is required on the participants admission to the 
Rehabilitation Unit. However this information is routinely collected on initial 
medical, nursing, physiotherapy and occupational therapy assessments. 
39 (c) Does the Participant Information Leaflet inform participants that their 
medical records will be examined, and by whom?  
Yes, they will be examined by the principal investigator Grace Coakley and the 
multi-disciplinary team 
ETHICAL CONSIDERATIONS 
 
40. Does the Chief Investigator consider that there are any specific ethical issues 
that this study might present and how would these be dealt with?  Please 
identify and evaluate.  No specific ethical issues are expected to present as this 
study's assessments form part of a comprehensive and evidence-based geriatric 
assessment and routine care in the Rehabilitation Unit of Cappagh National 
Orthopaedic Hospital. 
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Title of the Research Project: 
Quantitative Analysis of the Timed Up and Go in elderly patients post hip 
fracture in a sub-acute rehabilitation setting 
PLEASE ENSURE THAT YOU COMPLETE THE CHECKLIST ON THE 
FRONT COVER OF THE APPLICATION FORM AND ENCLOSE ALL 
RELEVANT ADDITIONAL DOCUMENTS. 
 
DECLARATION: 
 
I certify the information in this form is accurate to the best of my knowledge 
and belief and I understand my ethical and legal responsibilities as Chief 
Investigator of this study. 
 
I confirm that the protocol and research will comply with all relevant Irish 
legislative requirements and will be conducted in accordance with European 
Communities (Clinical Trials on Medicinal Products for Human Use) 
Regulations 2004 and will abide by the ethical principles outlined in the 
Declaration of Helsinki and Good Clinical Practice. 
 
If the study receives a favourable opinion I agree to supply Annual Progress 
Reports, a Final report, and to seek prior approval from the Ethics Committee 
of any proposed changes/amendments to this protocol.  
 
All relevant information about serious adverse reactions and new events likely 
to affect the safety of the subjects will be reported to the Ethics (Medical 
Research) Committee in accordance with the obligations outlined in the 
Commissions guideline document. 
 
Name of Chief Investigator:         ____________________________________ 
Signature of Chief Investigator:   ____________________________________ 
Date:                                             ____________________________________ 
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APPENDIX 3: CAPPAGH HOSPITAL ETHICS APPROVAL LETTER 
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APPENDIX 4: RCSI ETHICS APPROVAL LETTER 
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APPENDIX 5: GATEKEEPER CONSENT FORM 
 
 
Active Rehabilitation Unit 
Cappagh National Orthopaedic Hospital 
Finglas 
Dublin 11 
Research Ethics Committee 
Cappagh National Orthopaedic Hospital 
Finglas 
Dublin 11 
 
Title of Study: Quantitative Analysis of the Timed Up and Go in elderly patients post hip 
fracture in a sub-acute rehabilitation setting 
 
Principle Investigator: Grace Coakley, Basic Grade Physiotherapist, Active 
Rehabilitation Unit, Cappagh National Orthopaedic Hospital. Tel: 01 814 0419 
Research Supervisor: Dr. Dara Meldrum, Royal College of Surgeons Ireland, Email: 
dmeldrum@rcsi.ie 
 
Gatekeeper Consent Form 
I accept responsibility for providing potential participants with the initial information and 
will anonymise data if appropriate. 
 
Gatekeepers Signature                       ______________________________________ 
Gatekeepers Name (Block Capitals) ______________________________________ 
Date                                                       ______________________________________ 
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APPENDIX 6: PATIENT INFORMATION LEAFLET  
Title: Quantitative Analysis of the Timed Up and Go in elderly 
patients post hip fracture in a sub-acute rehabilitation setting. 
 
Principal investigator’s name:                Grace Coakley               
. 
Principal investigator’s title:     Basic Grade Physiotherapist  
.  
Telephone number of principal investigator:                01 814 0419                    
. 
Co-investigator’s name:             Dr. Dara Meldrum           
. 
Co-investigator’s title:                                              Lecturer, School of Physiotherapy, 
RCSI  
 
You are invited to take part in this research study. This leaflet will tell you about the 
purpose, risks and benefits of this study. Please read it carefully before you sign it.  
If there is anything you are not clear about, I will be happy to explain it to you. 
Please take as much time as you need to read it.  
If you agree to take part we would like to ask you to sign an informed consent 
document. You should only consent when you feel that you understand what is being 
asked of you and you have had enough time to think about your decision. Your 
participation is entirely voluntary. If you initially decide to take part you can 
subsequently change your mind without difficulty.  
Why is this study being done? 
The purpose of this study is to look at what changes happen to your walking ability 
as you undergo rehabilitation after your hip surgery. 
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Who is organising and funding this study? 
Grace Coakley, a Basic Grade Physiotherapist in the Active Rehabilitation 
Unit in Cappagh Hospital, is carrying out this study. Her supervisor is Dr. Dara 
Meldrum, Lecturer in Physiotherapy in the Royal College of Surgeons in Ireland. 
This study is part of a Masters Degree project. 
Why am I being asked to take part? 
You have been invited to take part as you were admitted to Cappagh rehabilitation 
unit after hip surgery to improve your mobility, function and ability to do tasks. 
How will the study be carried out? 
On admission to the Active Rehabilitation Unit in Cappagh Hospital, you will be 
invited to participate in the study by Ms. Coakley. If you decide not to take part in 
the study, it will not affect your care whilst in Cappagh Hospital. 
What will happen to me if I agree to take part? 
As part of this study you will be asked some personal details and how you feel about 
your health, mood and confidence in carrying out certain tasks. Your medical chart 
will be looked at to gather details of your medical background by the principle 
investigator Grace Coakley and the multidisciplinary team. This is part of a routine 
assessment. 
Assessments of your balance, mobility and strength will be carried out. Your 
walking ability will be assessed using sensors which will be attached to your legs 
using a strap during assessment. This session should take on average 45 minutes and 
if you become tired during the assessment you can take regular rests. You will 
receive regular physiotherapy whilst an inpatient in Cappagh Hospital. This will 
consist of walking practice, balance retraining and practice in general movement and 
transferring from bed to chair. You will also be given exercises to improve your 
strength in your arms and legs and your balance.  
These assessments will be repeated before your discharge from Cappagh Hospital.  
What are the benefits? 
This study is hoping to establish what changes happen to your walking ability as you 
undergo rehabilitation after your hip surgery. 
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This study will not affect the care you will receive whilst an inpatient in 
Cappagh. 
What are the risks? 
There is a very slight risk that you could lose your balance during the assessments. However 
this is very unlikely as you will be supervised very closely at all times by an experienced 
physiotherapist. 
If the medical team looking after you feels it is necessary, they may stop your participation 
in the study at any time without your consent. 
Is the study confidential? 
When you enter the study you will be assigned a unique number and this number will be 
used to identify you on study paper or computer files. Only the researchers will have access 
to these codes. Your name will not be published and will not be disclosed to anyone else. 
Information will be kept for 5 years and then destroyed by shredding paper files. The 
computerised data on you will then be numbered only and will be kept for future reference. 
 
Permission: 
Ethical Approval for this project has been granted by Cappagh National Orthopaedic 
Hospitals Research Ethics Committee. 
 
Where can I get further information? 
If you have any questions about the study or if you want to opt out of the study, this won't 
affect the quality of treatment you will receive.   
If you need further information at any stage, please contact:  
 
Principal Investigator: Grace Coakley  
Email Address: 
grace.coakley@cappagh.ie 
Phone No: 01 814 0419  
(Mon-Fri 08:00-16:30) 
Research Supervisor: Dr. Dara Meldrum 
Email Address: dmeldrum@rcsi.ie 
Phone No: 01 402 2368 
(Mon-Fri 09:00-17:00)
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APPENDIX 7: PARTICIPANT CONSENT FORM 
Principal Investigator: Grace Coakley, Basic Grade Physiotherapist, Active 
Rehabilitation Unit, Cappagh National Orthopaedic Hospital. Tel: 01 814 0419 
Research Supervisor: Dr. Dara Meldrum, Royal College of Surgeons in Ireland 
Contact email dmeldrum@rcsi.ie Tel: 01 402 2368 
 
 
 
Please tick the appropriate answer 
I have read and understood the Information Leaflet about this research project.  The 
information has been fully explained to me and I have been able to ask questions, all 
of which have been answered to my satisfaction. 
Yes  No  
I understand that I don’t have to take part in this study and that I can opt out at any 
time.  I understand that I don’t have to give a reason for opting out and I understand 
that opting out won’t affect my future medical care. 
Yes  No  
I am aware of the potential risks of this research study. Yes  No  
I have been given a copy of the Information Leaflet and this completed consent form 
for my records. Yes  No  
I give permission  for  material/data  to  be  stored  for  possible  future research 
related to the current study without further consent being required subject to 
research ethics committee approval.  
Yes  No  
 
Participant's Name:  
__________________________________________________________ 
 
Participant's Signature:  ___________________________________ Date:  ______________ 
 
To be completed by the Principal Investigator 
I, the undersigned have taken the time to fully explain the nature and purpose of this study to 
the above participant, in a manner that he/she can understand. I have explained that risks and 
the possible benefits involved and have invited him/her to ask questions on any aspect of the 
study that concerned them. 
Researcher's Name: _______________________________ 
Researcher's Signature:  ____________________________ Date:  
______________________ 
Title: Quantitative Analysis of the Timed Up and Go in elderly patients post 
hip fracture in a sub-acute rehabilitation setting. 
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APPENDIX 8: DATA COLLECTION FORM 
 
Principal investigator: Miss Grace Coakley, Senior Physiotherapist Cappagh Hospital, 
Tel: 01 814 0419 Supervisor: Dr. Dara Meldrum, Contact: dmeldrum@rcsi.ie 
Study number   
DOB (Age) Gender  M □              F□ 
 
Past medical history 
    
    
    
 
 
 
 
 
 
 
Presenting diagnosis  
Type of Fracture  
Type of Surgery  
Falls Hx (past year)  
LOS acute hospital  
Social Support (Please tick) 
Lives alone   □ Lives with family        □        Specify: ______________ 
Informal supports Family/other Support  □        Specify: ______________ 
Clinical Evaluations Admission 
New Mobility Score  
MOCA Score  
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Outcome Measures Admission Discharge 
TUG overall time   
Euro QoL VAS   
Falls Efficacy Scale   
Barthel Index   
Clinical Frailty Scale   
Grip-Strength (kgs)   
Tinetti Balance & Gait   
10MWT (sec)   
EMS   
Mobility and Transfers 
 Baseline self-report Admission T1 Discharge T2 
 Mobility  TFs Mobility  TFs Mobility  TFs 
Indp                            
Indp with aid       
Supervision 
with aid  
      
Supervision       
Assistance with 
aid 
      
Assistance        
Other       
Length of stay: 
Discharge Destination: 
Home no supports     □ Home Care Package   
New          □ 
Increase    □ 
Home Help 
New           □ 
Increase     □ 
Long Term Care        □ Readmission to acute    hospital    □ Deceased  □ 
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APPENDIX 9: NEW MOBILITY SCORE 
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APPENDIX 10: QTUG PROCEDURE 
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APPENDIX 11: QTUG SENSORS LAYOUT 
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APPENDIX 12: QTUG DATA SAMPLE 
 
 
 
 
 
 
Appendix 12: QTUG Data Sample 
 
 
97 
 
 
 
 
 
 
Appendix 12: QTUG Data Sample 
 
 
98 
 
 
 
 
 
 
Appendix 12: QTUG Data Sample 
 
 
99 
 
 
 
 
 
 
 
Appendix 12: QTUG Data Sample 
 
 
100 
 
Appendix 13: QTUG Fall Questionnaire   
 
101 
 
APPENDIX 13: QTUG FALL QUESTIONNAIRE 
 
Q1. Have you fallen in the past 12 months? 
 If yes, how many times? 
 
Q2. Have you had any problems walking or moving around? 
 
Q3. Are you taking 4 or more medications? 
 
Q4. Do you have any problems with your feet? 
 
Q5. Have you had any problems with your blood pressure dropping when you stand up? 
 
Q6. Do you feel dizzy when you stand up from a seated position? 
 
Q7. Do you have any problems with your vision? 
 
Q8. Have you had any change in your ability to manage your routine activities? 
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APPENDIX 14: TINETTI GAIT AND BALANCE ASSESSMENT 
 
 
B a l a n c e  A s s e s s m e n t   
Patient seated on a hard, armless chair 
 
Date Date 
Sitting Balance 
     0 = Leans or slides in the chair 
     1 = Steady, safe 
  
Rises from chair    
     0 = Unable without help 
     1 = Able, uses arms to help 
     2 = Able without using arms 
  
Attempts to rise  
     0 = Unable without help 
     1 = Able, requires > 1 attempt 
     2 = Able to rise, 1 attempt 
  
Immediate standing balance (first 5 seconds) 
     0 = Unsteady (staggers, moves feet, marked trunk sway) 
     1 = Steady, but uses walker or other support 
     2 = Steady without walker or other support 
  
Standing balance 
     0 = Unsteady 
     1 = Steady but wide stance (medial heels > 4” apart) / uses 
           cane or other support 
     2 = Narrow stance without support 
  
Nudged  
Subject at maximum stance position, (feet as close together as 
possible) examiner pushes lightly on subjects sternum with 
palm of hand 3 times 
     0 = Begins to fall 
     1 = Staggers, grabs but catches self 
     2 = Steady  
  
Eyes Closed   
At maximum stance position 
     0 = Unsteady 
     1 = Steady 
  
Turning 360 degrees 
     0 = Discontinuous steps 
     1 = Continuous steps 
  
Turning 360 degrees 
     0 = Unsteady, grabs, staggers 
     1 = Safe, smooth motion 
  
Sitting down 
     0 = Unsafe, misjudged distance, falls into chair 
     1 = Uses arms or not a smooth motion 
     2 = Safe, smooth motion 
  
 
Balance Score 
    
 
 
 16 
 
 
16 
 
 
Therapist name if signature not legible please print name → 
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G a i t  A s s e s s m e n t   
Initial instructions: subject stands with examiner.  Walks down 
hallway or across room, first at usual pace, then back at rapid 
but safe pace (using usual walking aids) 
 
Date Date 
Initiation of gait 
Immediately after told to “go” 
     0 = Any hesitancy or multiple attempts to start 
     1 = No hesitancy 
  
Step length   
     0 = Step to  
     1 = Step through Right 
     1 = Step through Left 
  
Foot Clearance 
     0 = inadequate foot clearance 
     1 = Left foot clears floor 
     1 = Right foot clears floor 
  
Step symmetry 
     0 = Right and left step length not equal (estimate) 
     1 = Right and left step length appear equal 
  
Step continuity 
     0 = Stopping or discontinuity between steps 
     1 = Steps appear continuous            
  
Path  
Excursion – observe over 10 foot distance 
     0 = Marked deviation 
     1 = Mild / moderate deviation or uses walking aid 
     2 = Straight without walking aid 
  
Trunk 
     0 = Marked sway or uses walking aid 
     1 = No sway but flexion at knees or back or spreads arms 
           out for stability while walking 
     2 = No sway, flexion, use of arms or walking aid 
  
Walking stance 
     0 = Heels apart wide base 
     1 = Heels almost touching whilst walking 
  
 
Mobility Score  
    
 
 
12 
 
 
12 
  
Total Score (Balance plus mobility) 
 
 
 
28 
 
 
28 
 
Therapist name if signature not legible please print name → 
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APPENDIX 15: CLINICAL FRAILTY SCALE 
 
 
Name CFS Admission CFS Discharge 
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APPENDIX 16: ELDERLY MOBILITY SCALE 
 
E L D E R L Y  M O B I L I T Y  S C A L E
 Dates → 
  
Lying to Sitting   (maximum score 2) 
2 Independent 
1 Needs help of 1 person 
0    Needs help of 2+ people 
  
Sitting to Lying   (maximum score 2) 
2 Independent 
1 Needs help of 1 person 
0    Needs help of 2+ people 
  
Sitting to Standing   (maximum score 3)  
3 Independent in under 3 seconds 
2 Independent in over 3 seconds 
1 Needs help of one person (verbal or physical) 
0    Needs help of 2+ people 
  
Standing   (maximum score 3)  
3 Stands without support* and able to reach 
2 Stands without support* but needs support to reach 
1 Stands but needs support* 
0 Stands only with physical support (ie. help of another 
person)                                  
*Support means needs to use upper limbs to steady self 
  
Gait   (maximum score 3)   
3 Independent (including use of 1 walking stick) 
2 Independent with frame, rollator, 2 sticks or crutches 
1 Mobile with walking aid but erratic/unsafe turning  
(needs occasional supervision) 
0    Needs physical help to walk or constant 
      supervision 
  
Timed Walk  -  6 meters   (maximum s core 3)  
3 Under 15 seconds 
2 16 – 30 seconds 
1 Over 30 seconds 
0    Unable to cover six meters 
 
 
 
 
  
Functional Reach   (maximum score 4)   
4 Over 20 cms. 
2 10 – 20 cms. 
0    Under 10 cms. or unable 
 
 
 
 
 
 
Total Score   (maximum score possible 20)  / 20 / 20 
Physiotherapist name 
 if signature not legible please print name → 
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APPENDIX 17: 10 METRE WALK TEST 
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APPENDIX 18: GRIP STRENGTH 
 
Instructions to subject: Hold your elbow at 90 degrees, squeeze the dynamometer 
as hard as you can, relax your grip and repeat two more times 
Instructions to rater: Ensure the subjects elbow is held at 90 degrees and the arm is 
not resting on the table. Calculate the average of the three scores 
Averaging three attempts is the most reliable measurement method (Matiowetz et al., 
1984). 
 
Date 
 
Right  
 
Left 
 
Right 
 
Left 
 1st      
2nd      
3rd      
 
Average 
Score 
    
 
Sign and 
Print name  
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APPENDIX 19: EUROQOL 5D 
 
Under each heading, please tick the ONE box that best describes your health 
TODAY  
 
MOBILITY  
I have no problems in walking about      
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
 
 
SELF-CARE  
I have no problems washing or dressing myself     
I have slight problems washing or dressing myself     
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself     
I am unable to wash or dress myself       
 
 
USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities)  
I have no problems doing my usual activities     
I have slight problems doing my usual activities     
I have moderate problems doing my usual activities    
I have severe problems doing my usual activities     
I am unable to do my usual activities      
 
 
PAIN / DISCOMFORT  
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
  
 
ANXIETY / DEPRESSION  
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed      
I am severely anxious or depressed       
I am extremely anxious or depressed     
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APPENDIX 20: BARTHEL INDEX 
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APPENDIX 21: FALLS EFFICACY SCALE 
 
 
